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Background: Tuberculosis (TB) is a leading cause of death from an infectious disease 
throughout the world. The incidence rate of TB in Taiwan remains higher than that of 
most developed countries. Mood disorders may have an important impact on the 
adherence to TB treatment. Taiwan’s government provided pay-for performance for TB 
programs (P4P) as an incentive; however, the impact of psychological factors on TB 
treatment is rarely recognized and studied. The aims of this study are 1) to investigate the 
prevalence and epidemiology of mood disorder, and examine patients' demographic 
characteristics and their associations among TB patients; 2) to evaluate the impact of 
mood disorder on TB treatment default and TB patients’ mortality; and 3) to examine the 
impact of P4P effect on TB treatment default and TB patients’ mortality. 
Methods: The secondary health insurance dataset from Taiwan National Health 
Insurance Research Database (NHIRD) and Taiwan CDC TB Register data were used for 
this study. The study population consists of all newly diagnosed TB patients from 2002 to 
December 2007 in Taiwan. Outcome measures include mood status, TB treatment default 
rate and mortality. We used Chi-square and multivariate regression to analyze the 
relationship between mood status, risk factors, P4P effect and TB treatment default. The 
Cox proportional hazards regression models was used to identify factors associated with 
death. Kaplan–Meier method was used to evaluate mood disorder and P4P program 
impact on patient survival.   
Results: The prevalence of mood disorder among TB patients was 26.75 % in Taiwan, 
this was two times higher than in the general population (12.6%). Anxiety was the 
 
 iii 
leading emotional problem (83.4%). TB patients who were elderly, females, and had 
higher income, disability, and high Charlson comorbidity index score (CCI) had a 
significantly higher chance of having a mood disorder. Risk factors for patients in the 
default group were having a mood disorder and being female. Regional level hospitals 
and family medicine specialties had the highest default rate (see glossary) Patients with 
mood disorders, were elderly, male, of lower income, disabled, and with high CCI had 
significantly higher risk of increased mortality. P4P in TB programs can decrease the 
default rate but had no significant influence on all-cause mortality.     
Conclusions: Our findings indicated that TB patients had a higher prevalence of mood 
disorders than in general population. Mood disorder posed as a barrier in TB treatment 
adherence. TB patients with mood disorder had significantly higher mortality and lower 
survival rates. P4P in TB programs was an effective incentive for decreasing default but 
no significant influence on all-cause mortality.  
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1.  CHAPTER ONE: INTRODUCTION 
1.1  Background 
 Tuberculosis (TB), a communicable disease, has been a major cause of death for 
thousands of years. Although there are currently many efforts to control this disease, 
which includes well-developed lab technology, standard treatment and a better healthcare 
delivery policy; TB is still a leading cause of death from infectious disease throughout the 
world (WHO, 2015c). Today, there is still an estimated nine million incident cases of TB 
globally, which is equivalent to roughly 125 cases per 100,000 population as seen in 2014. 
Nearly 60% of new TB cases occurred in the South-East Asia and Western Pacific 
Regions (WHO, 2015c). According to the report of Center of Disease Control in Taiwan 
(TCDC), the incidence rate of TB declined from 74.6 cases per 100,000 population in 
2002 to 49.4 per 100,000 population in 2013 (TCDC, 2014c)(Table 2.1). Compared to 
other developed countries, the TB incidence rate in Taiwan remains 17.9 times higher 
than the USA’s and 3.4 times higher than Japan’s (the rate in the USA was about 3.8 per 
100,000 population, 15 per 100,000 in the United Kingdom and 20 per 100,000 in Japan 
(TCDC, 2014c)(Table 2.2). A total of 1.5 million people died from TB in the year 2013 
(WHO, 2015c). TB morbidity and mortality are important indicators of public hygiene. 
The TB death rate was 3 per 100,000 population in Taiwan, which is also higher than that 
of the USA and Canada (0.15 per 100,000 population in USA, 0.21 per 100,000 
population in Canada)(TCDC, 2014c). This suggests that Taiwan needs to enhance 
management strategies to achieve the WHO’s goal, which is to have a TB incidence rate 
less than 1 per 100,000 population by 2050 (WHO, 2014a). 
Tuberculosis is widespread and affects many areas of life, including social policies. 
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Infectious pulmonary tuberculosis (PTB) is a very contagious disease that is transmitted 
by air through various airways, such as the nose and the mouth. It can lead to widespread 
infections if not properly controlled: 1 billion individuals may become infected, 150 
million would exhibit symptoms, and 36 million may die from infection between 2002 to 
2020 (WHO, 2014a). Today, the treatment procedure for TB is standardized, and patients 
can be cured as long as they follow medical instruction (TCDC, 2015). In fact, many 
researchers reveal that the failure to follow the TB treatment is mainly attributed to non-
completion of treatment and noncompliance of the prescribed drug regimens. Medication 
non-compliance has been recognized as one of the most critical challenges in achieving 
successful management of this disease (Chung, Chang, & Yang, 2007; Gelmanova et al., 
2007; Kruijshaar et al., 2010; Munro, 2007; Neves, Reis, & Gir, 2010; WHO, 1997). 
Noncompliance to medication treatment for tuberculosis is a serious issue that, if not 
properly dealt with, can lead to failure of the drug treatment, relapses of symptoms, and 
the emergence of drug resistance. It has been found that there are strains of tuberculosis 
that are resistant to many drugs and as such, have been thought to be associated with 
diminished mental health, the loss of work and social relationships, as well as feelings of 
hopelessness and stigma (Baghaei et al., 2011; Chang, Chiu, Chiang, Lu, & Liou, 2011; 
Courtwright, 2010; Gelmanova, et al., 2007; Jiang, Yen, & Wang, 2011; L. Li et al., 2009; 
Neves, et al., 2010; Annika Sweetland, Albújar, & Echevarria, 2002; Tulsky JP, 2004).  
Mood disorder has an important effect on adherence to treatment for many health 
conditions such as HIV, tuberculosis, diabetes, etc (Prince M, 2007). TB is associated 
with psychiatric morbidity, a particularly depressive disorder that has been recognized as 
a cause of poor compliance as well as increased morbidity and mortality to the disease. 
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Despite this recognition, the amount of research that has been put into co-morbidities 
between tuberculosis and common mental disorders is surprisingly low. Little attention 
has been given to the identification of mood disorder among TB patients, particularly in 
Taiwan. No study yet has examined the prevalence rate of mood disorder among TB 
patients and evaluated its impact on TB treatment outcomes in Taiwan. The Bureau of 
National Health Insurance (BNHI) in Taiwan initiated the pay-for-performance (P4P) 
program in November 2001, which gave healthcare providers incentives to provide TB 
patients with more holistic care. It is anticipated that healthcare providers will provide TB 
patients not only with better physical care but also with psychological and social health 
care under this program. However, The impact of the P4P program on TB treatment 
outcomes for patients with both TB and mood disorder remains unknown. 
1.2  Study Aims 
 This study aims: 1) to investigate the prevalence and epidemiology of mood disorder, 
and examine patients' demographic characteristics and their associations among TB 
patients; 2) to evaluate the impact of mood disorder on TB treatment default and TB 
patients’ mortality; and 3) to examine the impact of P4P effect on TB treatment default 
and TB patients’ mortality. 
1.3  Significance 
 The results of the proposed study can provide more information for policy makers to 
shape a better TB control plan in Taiwan. If mood disorder among TB patients adversely 
affects TB treatment compliance, it may be important to encourage clinicians to pay more 
attention to their TB patients’ mental conditions, screen TB patients for depressive 
symptoms, as well as refer these patients to mental health professionals, to monitor their 
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compliance with treatment. 
  
2.  CHAPTER TWO LITERATURE REVIEW  
2.1  Tuberculosis (TB) 
2.1.1  TB disease description 
 Tuberculosis (TB) is still prevalent worldwide today, especially in undeveloped and 
developing countries. TB is a chronic infectious disease caused by Mycobacterium 
tuberculosis. It is spread through the air from one person to another. The TB bacteria are 
dispersed into the air when a person with TB disease of the lungs or throat coughs, 
sneezes, speaks, or sings. These bacteria can usually stay in the air for several hours, 
depending on the environment. People nearby may breathe in these bacteria and become 
infected. Most people who are infected with Mycobacterium tuberculosis are initially 
protected by the host’s immune system. People, who first initially become infected, due 
to their immunity, will not become sick; this occurs in about 95 percent of infected 
individuals and is called latent TB infection. There will be life-long re-activation and 
there may be a potential danger to the host. If there is an onset of a disease affecting the 
immune system (such as AIDS), a disease whose treatment affects the immune system 
(such as chemotherapy in cancer or systemic steroids in asthma, SLE, or arthritis), a 
disease in an older individual, or malnutrition, the immune system may be compromised 
and may lead to its degradation (CDC, 2012; Sutherland, 1976; WHO, 2011). This can be 
dangerous for an individual because a latent tuberculosis infection has the potential to 
develop into tuberculosis at any time.  
A TB infection spreads through the blood or lymphatic system to the lungs to cause 
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extra-pulmonary tuberculosis (such as tuberculosis meningitis) in only 5% of those with 
an early TB infection. TB can occur in any organ or tissue of the body, such as the lymph 
nodes, meninges, pleura, kidney, bone, skin, digestive tract, or urogenital tract, but the 
incidence of extra-pulmonary is much lower compared to pulmonary TB.  
2.1.2  Symptoms of TB 
 Symptoms of TB depend on the part of the body infected. The lung is the most 
common place where the bacteria usually grow. TB in the lungs may cause symptoms 
such as a bad cough that can last 3 weeks or longer, pain in the chest, the coughing up of 
blood or sputum (phlegm from deep inside the lungs). Other symptoms of TB are 
weakness or fatigue, weight loss, no appetite, chills, fever, and sweating at night. 
Symptoms of TB in other parts of the body depend on the area affected (Hsueh et al., 
2006).  
2.1.3  Screening and diagnosis of TB 
 Finding Mycobacterium tuberculosis in sputum (TB culture or smear) is the most 
important diagnostic evidence for the disease. Sputum of TB patients is contagious and is 
a key target of TB control. Chest X-rays may be used to rule out the possibility of 
pulmonary TB in a person who has had a positive reaction to a Mantoux tuberculin skin 
test (TST) or a positive TB blood test, and has no symptoms of the disease. Lesions may 
appear anywhere in the lungs and may differ in size, shape, density, and cavitation. 
2.1.4  TB treatment  
 TB is treated using WHO-recommended regimens. The initial phase consists of two 
months of isoniazid (INH), ethambutol (EMB), rifampin (RMP) and pyrazinamide (Z), 




 According to an investigation by WHO, if patients take the medicine regularly, the 
one-year cure rate can reach 95% or higher. The failure of TB treatment is mainly 
attributed to non-completion of treatment and noncompliance to the prescribed drug 
regimens (TCDC, 2015; WHO, 2005, 2014b). Multidrug-resistant TB (MDR-TB) is 
defined as TB caused by organisms resistant to at least isoniazid (INH) and rifampin 
(RMP). MDR-TB is difficult to treat and generally requires a minimum of 18–24 months 
of therapy with second-line medications that are less effective and more toxic. 
2.1.5  The burden of disease caused by TB 
 According the report from WHO, the incidence of TB is generally greater in men 
than in women, greater in the elderly than in the young, and greater in the lower social 
classes than in the higher social classes. The prevalence of TB is low in developed 
countries, where most cases are intrinsic (endogenous), that is, from the old fibrosis or 
calcification reactivation. On the contrary, in developing and undeveloped countries, the 
prevalence of TB is high and is mostly due to external infection (WHO, 2011). 
In the United States, there was a steady 5–6% annual decline in the case rate of TB. 
TB was found to be associated with HIV infection, homelessness, drug use, foreign birth 
and racial/ethnic minority status. Before 1986, foreign-born persons accounted for 22% 
of TB cases; by 1997, this had increased to 39% and in 2007 it had reached 58% (Murray 
et al., 2014). The TB case rate in 2011 for foreign-born persons was 12 times greater than 
the rate for US-born persons, and for Blacks it was 8.5 times greater than for Whites 
(CDC, 2012; Che & Antoine, 2009). 
In Taiwan, the incidence rate of TB declined from 74.6 cases per 100,000 population 
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in 2002 to 49.4 per 100,000 population in 2013 (TCDC, 2014c) (Table 2.1). The mortality 
of TB also went down from 5.68 per 100,000 population in 2002 to 2.7 per 100,000 
population in 2013. Tuberculosis control in Taiwan is still well behind TB control in 
developed countries. Taiwan's CDC declared on World Health Day 2005, that the number 
of tuberculosis patients would be halved in ten years (TCDC, 2014a). That is, incidence 
would drop from 16,472 new cases each year to 7500. Until 2014 the incidence of TB in 
Taiwan was still around 11,610. WHO had proposed a new post-2015 Global TB 
Strategy in May, 2014 (WHO, 2015b). The new targets are to reduce TB deaths by 95% 
and to decrease new cases by 90% between 2015 and 2035. Much progress is needed for 
prevention of TB in Taiwan.  
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Table 2.1 Taiwan TB Incidence and Mortality Rate, 2002 – 2013 
 
  Year Case Incidence Death Mortality 
2002 16,758 74.6 1,277 5.68 
2003 15,042 66.67 1,309 5.8 
2004 16,784 74.1 957 4.23 
2005 16,472 72.5 970 4.3 
2006 15,378 67.4 832 3.6 
2007 14,480 63.2 783 3.4 
2008 14,265 62.0 762 3.3 
2009 13,336 57.8 748 3.2 
2010 13,237 57.2 645 2.8 
2011 12,634 54.5 638 2.8 
2012 12,338 53.0 626 2.7 
2013 11,528 49.4 621 2.7 









The demographic characteristics of the TB cases were described as following 
(TCDC, 2014c): 
1. By gender: The male to female ratio was 2.3 : 1. 
2. By age: Most cases fell in the age group of ≧65 years which accounted for 52.1% of 
total cases. Incidence increased with age. The lowest incidence occurred among the 0-14 
years of age group. 
3. By month (based on notification date): cases were spread out throughout the year; no 
epidemic season was found. 
4. By region: Cases occurred more frequently in the metropolitan area such as Taipei, 
Taichung and Kaohsiung city than in rural areas, and more in the South than in the North 













TB patients' mortality in Taiwan in 2013(TCDC, 2014b): 
1. By gender: There were 479 deaths among males and 147 deaths among females. The 
male to female death ratio was 3.26: 1. The male mortality rate was 4.1 cases per 100,000 
population and the female mortality rate was 1.3 cases per 100,000.  
2. By age group: The tuberculosis mortality rate increased with age. Of the 621 
tuberculosis deaths in 2013, 83% (519/621) were of elderly individuals aged 65 years and 
over. 
3. By area: The tuberculosis mortality rate was the highest in Taitung County with a rate 
of 9.2 cases per 100,000 population, followed by Hualien County (6.8 cases per 100,000 
population), and then Kinmen County (6.3 cases per 100,000 population), according to 
the Surveillance Reports of Selected Diseases. The overall distribution of deaths by 
tuberculosis in 2013 exhibited a pattern of a higher mortality rate in the east and south 
and a lower rate in the north (TCDC, 2014c).  
 In recent years, transportation has become more convenient. People have greater 
chances of interacting with each other. TB has become easier to transmit. From table 2.2, 
we may compare the burden of TB in Taiwan with major developed countries and other 
adjacent Asian countries such as mainland China, Philippines, Indonesia and India. The 
TB incidence and prevalence rate in the Southeast Asian countries are obviously higher 
than Taiwan and most developed countries. Raising awareness and building an 
international interchange network is important in order to protect people from TB.  
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2.2   Tuberculosis with Mood Disorder   
2.2.1   Mood Disorder  
 Mood disorder is a symptom that can be used to anticipate the beginning, as well as 
the advancement, of physical and relational disabilities. On the other hand, a disability 
can be an indicator for depression in older adults (Bruce, Seeman, Merrill, & Blazer, 
1994; Cole & Dendukuri, 2003; Holwerda et al., 2007). Several studies show the 
biological effects of depression on the human body. The effect on serotonin metabolism 
changes cardiac function, platelet aggregation, and vasoconstriction (McCaffery et al., 
2006). Additionally, depression effects cortisol metabolism by increasing cortisol 
production, which leads to inflammation. It also affects cell-mediated immunity that 
impairs T-cell mediated function, where a reduced natural-killer cell count increases 
vulnerability to infectious diseases (Zorrilla et al., 2001). Furthermore, many diseases 
create a psychological burden due to lifestyle changes, unpleasant side effects from 
therapeutic regimens, feelings of stigma, pain, the loss of social support, the breaking 
down of key relationships, having a life-threatening disease, and difficulty of living with 
the illness (Bratek, Zawada, Barczyk, Sozanska, & Krysta, 2013). This psychological 
burden may trigger mood disorder in an individual, delay help-seeking, cause them to 
withdraw from treatment, and perhaps even worsen the prognosis. 
 
2.2.2  Tuberculosis and Mood Disorder  
 In 2007, Lancet had a series of articles related to mental health and disease. These 
articles showed that mental disorders increase the risk for communicable and non-
communicable diseases. Conversely, many health conditions increase the risk for mental 
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disorder, and co-morbidity complicates help-seeking, diagnosis, treatment, and influences 
prognosis (Andrews & Titov, 2007; Prince M, 2007). According to a WHO report in 2005, 
neuropsychiatric conditions accounted for 31.7% of all years-lived-with-disability (WHO, 
2005). Depression is the major contributor to this disability (unipolar depression, 11.8%, 
and bipolar depression, 2.4%). A WHO World Health Survey in 2007 studied 245,404 
adults aged 18 years and older from 60 countries in all regions of the world. This survey 
showed that compared with other chronic diseases such as angina, arthritis, asthma, and 
diabetes, mood disorder produced the greatest decrement in healing (Moussavi et al., 
2007). 
In recent years, the pharmacological treatment of TB has been well established. The 
standard anti-TB therapy consists of four medications and takes at least six to nine 
months to complete. Most TB patients need to tolerate serious risks of adverse reactions 
such as skin rashes, pruritus, hepatitis, nausea/vomiting, thrombocytopenia, influenza-
like illness, arthralgia and neuropsychiatric symptoms (Marra et al., 2007). Hence, it is 
crucial to help patients adhere to drug regimens to reduce the risk of resistance. However, 
compliance to treatment is sometimes difficult among patients, particularly those with co-
morbid psychiatric disorders. Patients with personality disorders may not recognize the 
necessity of treatment for their well-being. Residential treatment and isolation are 
sometimes used for TB-positive psychiatric patients to limit the spread of the disease. 
While these practices may increase compliance, they may induce further emotional stress. 
 In the United States, some communities of TB patients are perceived as a source of 
infection and the resulting social rejection and isolation leads to long-term impairment in 
patients' psychosocial well-being. Many TB patients also report experiencing negative 
 
 16 
emotions, such as depression, anxiety and fear (Kelly, 1999). According to Rubel’s and 
Garro’s study among Mexican immigrants in 1992, Ailinger’s and Dear’s survey in 
Latino immigrants in 1997, and Carey and colleagues’ findings in a Vietnamese refuge in 
New York State, nearly all respondents had concerns that a tuberculosis diagnosis would 
lead to termination from their jobs and avoidance by their family and friends. Patients 
responded to these attitudes by isolating themselves and becoming secretive about their 
illness (Ailinger & Dear, 1998; Carey et al., 1997; Rubel & Garro, 1992). The 
psychosocial impairment experienced by TB patients may be a reflection of socio-
demographic status (e.g., age, gender, and socio-economic status) and other underlying 
co-morbid conditions, besides TB and its treatment (Caracta, 2003; Nyamathi, Berg, 
Jones, & Leake, 2005; Uplekar et al., 2001). A few studies explored the relationship 
between socio-demographic features, clinical factors, and psychosocial well-being in TB 
patients. In general, the findings were consistent, but some discrepancies existed. Yang et. 
al. and Nyamatihi et. al. observed that females were more likely to report poorer health 
than males, especially regarding mental health problems, such as depression and anxiety 
(Nyamathi, et al., 2005; L. Yang, Wu, Guo, & Liu, 2003). Guo et. al. found that older 
individuals tended to have a poorer health-related quality of life than younger individuals. 
However, Duyan et. al. did not find significant associations between gender, age and 
quality of life in TB patients (Duyan, Kurt, Aktas, Duyan, & Kulkul, 2005; Guo et al., 
2008). Instead, they found that better health-related quality of life was correlated with 
higher income, higher education, better housing conditions, better social security, and 
closer relationships with family and friends. 
 Although a few studies have conducted research related to depression and several 
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other diseases, such as diabetes, cardiovascular disease, COPD and HIV, there is little 
research on the relationship between mood disorder and tuberculosis. Estimates of the 
prevalence of mood disorder in patients with TB vary widely. There have been few 
available studies regarding the prevalence of co-morbid TB and mood disorder in 




Table 2.3 Prevalence of Mood disorder among TB patients 
 
Studies Screening Tools Prevalence of Mood 













19% for RDtb, 21.6% for 
Dtb, 25.6% for MDRtb 
Turkey, 
inpatient 
20–66yr 119 male 
Vega et al., 2004 Clinical criteria 
based on DSM-IV 
52.2% for MDRtb； 
13.3% after anti-TB, and 






37 (49.3%) male 
38 (50.7%) female 





72% for RDtb 






the Hospital Anxiety 
and 
Depression scale 
(HADS) and the 
Illness Perception 
Questionnaire (IPQ). 
50 (46.3%) depressed 51 
(47.2%) anxiety 
Negative illness 
perceptions were related 






Rajeswari, 2005 SF36 depression 
(male 7%, female 10%) 
suicidal thoughts (male 






Kruijshaar, et al., 
2010 




at diagnosis (high) 
anxiety scores 48  
























RDtb= recently diagnosed TB; Dtb= defaulted TB; MDRtb= multidrug resistant tuberculosis; DSM-IV 
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 Most of these studies used the Hospital Anxiety and Depression Scale (HADS) 
as a screening tool for depression. The majority of the studies were conducted in 
developing countries (Aamir & Aisha, 2010; Aydin & Ulusahin, 2001; Mohammed O 
Husain, 2008; Pan, Zhao, & Yang, 2006; Rajeswari, 2005; Vega et al., 2004). In the UK 
study, a large proportion of the participants with TB were not born in the UK, most were 
Indian, Pakistani, or Bangladeshi (33%) and Black African (28%) (Kruijshaar, et al., 
2010). Only one study was made up of Chinese individuals; but it had a small sample size 
and did not comprehensively cover the whole country. In regard to gender distribution, 
there were more males than females. Most females were from lower socioeconomic 
levels, and were illiterate. The average age of the individuals in these studies was less 
than 45 years old. The prevalence of depression in patients with TB was high upon 
diagnosis of tuberculosis, but declined after patients were recruited into psychotherapy, 
joined a support group, or went on drug therapy. In the UK study, higher rates of 
depression and anxiety were observed in the TB patients that did not comply to treatment, 
as well as those with more negative health beliefs. Therefore, when patients perceived a 
greater risk of TB, mood symptoms became more apparent. In general, the prevalence of 
mood disorder and anxiety is higher in those with tuberculosis than in the general 
population. The incidence of depression, anxiety, and psychosis emerging during the 
course of treatment for tuberculosis is also higher in affected individuals than in the 
general population. Mood disorder and lack of perceived control were independently 
associated with poor adherence. Treating psychological problems in patients with 
tuberculosis may substantially improve treatment adherence. It is noticed that Isoniazid 
(H), a commonly used anti-TB drug, had been reported to possibly lead to mental 
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syndromes and suicidal thoughts (Djibo & Lawan, 2001; Herrag, Sajiai, & Yazidi, 2011; 
Iannaccone, Sue, & Avner, 2002; Pallone, Goldman, & Fuller, 1993; Shah, 2009). For 
these reasons, it is crucial to pay more attention to the psychological status of TB patients. 
 In Taiwan, no study has examined the prevalence of mood disorder among TB 
patients, particularly patient characteristics that may be different from those in other 
countries. According to the report from the Taiwan CDC, male TB patients are more 
susceptible to TB than females; and most of those infected are elderly. In Taiwan, there is 
minimal disparity in the living standard, and the illiteracy rate is very low. However, 
even though the government has devoted many resources and manpower, such as pay-for 
performance and case management, to eradicate TB, it is still unknown how mental 
factors play a role with the disease in Taiwan’s population. 
 
2.3  Health delivery system and TB  
2.3.1  Pay-for-performance (P4P) and TB 
 Payment systems work as different incentives to the various medical service 
providers; they affect medical outcomes, doctor-patient relationships, and patients' rights. 
Traditional payment systems can be broadly divided into: fee for service, case payment, 
capitation payment, total payment system (global budget), per diem, and salary (Lagarde 
M., 2010). While each of these systems has their advantages and disadvantages, many 
existing reimbursement plans do not reward high quality health care. For example, under 
the Diagnoses Related Groups (DRGs) system or global budget, hospitals tend to reduce 
the inputs into the treatment process or expenses because they are compensated by a fixed 
amount determined by each patient’s diagnosis or by a fixed quota, rather than the 
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marginal cost incurred during the treatment. These traditional payment designs can result 
in problems of overuse, underuse, and low productivity. 
Reports from the Institute of Medicine on issues concerning quality of health care 
have led to research on payment reform and implementation of the P4P scheme. The pay-
by-quality payment method was established based on disease management. P4P is a 
modification of the traditional payment scheme and is based on rewarding health care 
providers for the quality of their care with financial or other non-financial incentives 
(Hackbarth, 2008; Mabotuwana et al., 2010; Mullen, Frank, & Rosenthal, 2010; 
Rosenthal, 2008; Vamos et al., 2011; Witter, Fretheim, Kessy, & Lindahl, 2012). The 
theoretical basis for designing an incentive mechanism within a payment scheme 
originated from the agent theory, which posits that incentive contracting occurs when an 
individual or organization induces and rewards another individual or organization for 
specific behaviors (Lindenauer et al., 2007). The concept of P4P brings both continuous 
and better healthcare, as well as case management into the medical care services. Case 
management is usually composed mainly of nurses, physicians, and public health workers 
or social workers (Hsieh et al., 2008). These individuals are in charge of handling the 
condition and treatment of the infected person through the treatment process, patient 
education, medication side effect evaluation, compliance assessments and anything else 
the physician may require. The objective behind the case managements were launched in 
TB control to incur better treatment outcomes as well as improve quality of life for the 
patients.  
Hence, the performance based incentives influence provider behavior at both the 
individual health worker and the institution level. At the individual level, incentives are 
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aimed at improving the quality of diagnosis, expanding access to treatment by promoting 
outreach, reducing default rates, and encouraging completion of treatment. Performance 
based incentives aimed at the team or institution level are oriented towards improving 
team work and stimulating system changes to improve outcomes. Payment is usually 
based on a clearly defined process or outcome measures, such as: case detection, suspect 
referral, completion of treatment, or cured patient.  
 
2.3.2  Healthcare providers for TB in Taiwan 
 In 1995, Taiwan implemented a compulsory universal health insurance program to 
provide universal health insurance coverage to all of its citizens. Implementation of this 
program involved extensive and comprehensive changes for all healthcare delivery 
systems, including the TB control system (Cheng & Chiang, 1997). The formerly 
centralized, government-budgeted, and vertically structured health system was reformed 
into a liberalized system with fragmented organization and distributed responsibility for 
TB control. The official TB control institutes were nearly all abolished and only one of 
the chest-specialized institutes located in Southern Taiwan remains. This universal health 
insurance program maintains a contract with more than 90% of Taiwan's health care 
institutions and works without a referral system; insured patients are completely free to 
choose their physician or hospital. Thus, all patients with TB can freely seek medical aid 
at any healthcare institution from offices of primary practitioners to hospitals. Since that 
time, TB cases have been identified and treated in general care facilities. 
The registration for TB patients started from 1957. It was aimed at sputum positive 
infectious tuberculosis patients. Thereafter, the target was expanded.  Starting in 1991, 
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all active tuberculosis patients were to be notified and registered. However, the process of 
notification in medical centers was not performed smoothly enough to accurately reflect 
epidemic situation. The Bureau of National Health Insurance enforced the policy of "No 
Notification, No Payment" for TB in July 1997. In 2001, CDC has set up the TB Division 
to handle the notification of TB Death Data for matching and notification through the 
Internet (suspected cases were also included). Consequently, different methods of 
notification produced different notification rates. As a result, the number of TB patients 
notified by medical centers rose rapidly. The epidemic statistic data notification rate has 
come closer to the true epidemic situation.  
Many studies have shown the association between hospital level and ownership 
information and TB-related policies and outcome performances (Hu, 2005; Tsai et al., 
2010; Yu-Wei Hsieh, 2011; Yun-Hsiang Chan, 2011). Hospital level and ownership are 
important considerations in the empirical study of the health economy and medical 
management. The different hospital levels represent different service functions, task and 
development objectives, and also reflect the information of the number of beds (hospital 
size) and hospital accreditation results (i.e. quality of care). In general, the higher the rank 
of the hospital in regards to the hospital's medical resources, the better the quality of 
healthcare. The different ownership of the medical institutions represents different tax 
burdens for the facility (ex. public medical institutions can be exempted from business 
tax, income tax, house tax, etc.) and different operational objectives and management 
style (ex. the financial allocation of public and private hospitals). In Taiwan medical 
institutions are classified into four major accreditation levels: academic medical center, 
regional hospital, district hospital, or clinic. The accreditation criteria include 
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infrastructure, capacity, manpower, volume, management and administrative processes. 
The NHI as a single payer who reimburses providers by provider accreditation level, 
quality of care or provider level. The academic medical centers tend to get the highest fee 
and clinics tend to get the lowest fee for most services. More than 90% of the hospitals 
are private, not-for-profit; and, approximately 97% of the clinics are privately owned. 
Taiwan has a closed hospital system, most hospital physicians are under contract and 
have their salaries paid by the hospital. Our study will use these variables to evaluate the 
influence of health care providers on mood disorder TB patients. 
2.3.3   P4P on Tuberculosis in Taiwan 
 In recent years, Taiwan's National Health Insurance program implemented a quality 
payment system for the treatment of breast cancer, tuberculosis, diabetes, asthma, and 
hypertension. In order to make TB treatment more effective and avoid rapid spread of the 
disease, the Bureau of National Health Insurance (BNHI) in Taiwan started the 
implementation of a P4P payment demonstration project for the treatment of TB in 
central Taiwan in October, 2001. By January of 2004, P4P became a national program. 
According to the report from the CDC, there had been a total of 250 hospitals in Taiwan 
participating in the pay-for-performance program for TB by June, 2006; and, about 70% 
of TB patients were covered by this program. The P4P program for TB treatment aimed 
to improve patient treatment compliance to increase the TB treatment success rate and 
reduce the financial burden of the NHI from TB patients in Taiwan. Hospitals in Taiwan 
could choose to join the P4P plan if they met the following criteria: (1) if hospitals 
choose to join P4P for TB, they should have a health insurance contract with the BNHI; 
(2) hospitals should be approved by the CDC of Taiwan; (3) physicians in the 
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participated hospital must have specialist licenses on infectious disease, tuberculosis, 
chest medicine or have had related training or certification; (4) if the hospital has more 
than 100 new cases in one year, the hospital must hire a full time TB case manager. 
 The P4P program is a TB treatment plan that is broken up into 4 phases; each phases 
lasts for 3 months. In the P4P for TB plan, health care providers can get a bonus if they 
can accomplish the care task in each phase without interruptions or drop out. The most 
typical conditions of putting into action the P4P to control diseases is the reward health 
care providers can earn. The rewards vary by stage of the P4P program, please see the 
appendix A   
 
2.3.4  Mood Disorder and P4P on Tuberculosis in Taiwan 
 Previous literature suggests that mental distress is very common in TB patients. 
However, there are rarely psychological professionals involved in a TB case management 
team or P4P care program. When we look up a “TB management record card”, there are 
no psychological observational records. Also, on the official “national surveillance 
network of communicable disease” follow up system, there is no mental condition record. 
Although using the psychological screening tool to evaluate TB patients has rarely been 
done, it can be seen that the impact of mood disorder among TB patients has been 
neglected. 
A few studies have found that the outcome of P4P on TB cases in Taiwan has been 
beneficial. In Hsieh’s study, the P4P program improved the treatment success rate by 
approximately 13% on average and it was most effective at the lowest leveled hospital 
(Hsieh, et al., 2008). Tsai also found that the default rate declined after "P4P on TB" 
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implementation (Tsai, et al., 2010). The study by Li showed that both the cure rate and 
average length of treatment for cured cases improved after the implementation of the P4P 
for TB in Taiwan (Y. H. Li et al., 2010). Hospitals using case management with DOTS 
were able to improve adherence to medication by tuberculosis patients (Hsieh, et al., 
2008). Although a few studies have discussed the effectiveness of the P4P policy, no 
quantitative study yet discussed the major mental impact of TB on patients. It is believed 
that since physicians and hospitals gain financial incentives from the P4P program, they 
should be providing TB patients not only with physical care but also psychological and 
social healthcare as well. However, the current goal of TB management is to achieve a 
microbiological “cure” and there has been little effort taken to consider patients’ 
psychosocial well-being. Therefore, there is a need to explore whether the P4P policy 
will mend the impact of mood disorder in TB patients.
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3.  CHAPTER THREE MATERIALS AND METHODS 
3.1  Conceptual Framework 
 I adopted Donabedian’s structure-process-outcome model (see Figure 3.1) 
(Donabedian, 1966) for the conceptual framework of this study (see Figure 3.2). This 
model is widely used in studies regarding the quality of care provided to patients. It 
models the quality of care as a three-dimension categorization that includes structure, 
process, and outcome. The structure aspect indicates the hospital characteristics that 
influence the health care provided, such as human, physical, and financial resources. 
Process refers to the actual care-related services that are given by health providers to 
patients. The process of the care provided is not only determined by health care providers 
but also by patients and their families. The process aspect of care is also influenced by 
the structure variables. Outcome is defined as “changes (desirable or undesirable) in 
individuals and populations that can be attributed to healthcare.” It can be affected by 
both structure and process. In the proposed study, I modified Donabedian’s structure-
process-outcome model to fit the traits for TB care and treatment. I also included patient 
characteristics as they are important indicators for TB outcomes and the process of care. 








Figure 3.1 Dimensions of quality of healthcare. Adapted from Donabedian 
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Figure 3.2 Conceptual Framework for the Study 
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3.2  Research Questions and Hypotheses: 
 To achieve the research aim 1) to investigate the prevalence and epidemiology of 
mood disorder, and examine patients' demographic characteristics and their relationship 
among TB patients in Taiwan, the research questions and hypotheses are: 
Research question 1: What is the prevalence of mood disorder among TB patients in 
Taiwan?  
Hypothesis 1: The prevalence of mood disorder is higher in TB patients than in the 
general population in Taiwan. 
Research question 2: Among TB patients, what patients' characteristics are associated 
with the presence of mood disorder in Taiwan?  
Hypothesis 2: Patient’s age, gender, socio-economic status, location of residence, 
disability and other co-morbidities are associated with the presence of mood disorder 
among TB patients. 
 To achieve the research aim 2) to evaluate the impact of mood disorder on TB 
treatment default and TB patients’ mortality, the research questions and hypotheses are: 
Research question 3: Do TB patients with mood disorder have the same rate of 
treatment default rate as TB patients without mood disorder in Taiwan?  
Hypothesis 3: TB patients with mood disorder have a higher default rate than TB 
patients without mood disorder in Taiwan.  
Research question 4: Do TB patients with mood disorder have the same mortality as TB 
patients without mood disorder in Taiwan?  
Hypothesis 4: TB patients with mood disorder have a higher mortality rate than TB 
patients without mood disorder in Taiwan.  
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 To achieve the research aim 3) to examine the impact of mood disorder and P4P 
effect on TB patients' mortality, the research questions and hypotheses are: 
Research question 5: Does P4P with the TB program improve TB  treatment default 
rate among TB with mood disorder patients ?  
Hypothesis 5: TB patients with mood disorder enrolled in the P4P program have a higher 
default rate than those patients who are not enrolled in the P4P program in Taiwan.  
Research question 6: Does P4P with TB program improve mortality among TB with 
mood disorder patients. 
Hypothesis 6: TB patients with mood disorder enrolled in the P4P program will have a 
lower mortality rate than those patients who are not enrolled in the P4P program in 
Taiwan.  
 
3.3  Research Methods and Design 
3.3.1  Study Design 
 Using the national data sets from the Bureau of National Health Insurance and the 
Taiwan Center for Disease Control and Prevention (TCDC), this study enrolled the newly 
developed TB cases from the years 2002 to 2007 and observed their TB therapy and 
outcome until 2010 in Taiwan to describe the epidemiology of TB and mood disorder co-
morbidities and to evaluate the impact of P4P on TB program. 
3.3.2  Data Sources 
National Health Insurance Research Database (NHIRD) 
 Taiwan developed a unique health insurance system based on a single-payer 
government run National Health Insurance (NHI) Program in March 1995. By 2010, the 
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NHI provided coverage for more than 99% of Taiwan’s population (23.74 million people). 
The National Health Insurance Research Dataset (NHIRD) is managed by the Bureau of 
National Health Insurance (BNHI). The dataset contains original claim data for all of the 
reimbursed healthcare services. We retrieved data from the NHIRD (Longitudinal Health 
Insurance Database 2000; LHID 2000) from 1,000,000 randomly sampled persons who 
had enrolled in 2000. All of the data for enrollees from 2000 to 2010 were de-identified 
and further scrambled by the National Health Research Institutes in Taiwan before release. 
It includes historical claims data for 1 million subjects randomly selected from the 23.74 
million individuals insured by the NHI program. In this study, I use the data file for the 
ambulatory services and in-patient to identify patients with TB and mood disorder using 
the diagnosis codes. The data file provides patient characteristics, including gender, age, 
insurance premium, location of residence, status of disability and co-morbidity. The data 
file also indicates which health care facility the patient visits and which physician the 
patient sees. The facility ID and healthcare provider ID in the ambulatory service data file 
will allow me to link the file to the facility data file and the medical personnel data file, 
where I can obtain facility characteristics (e.g., level, ownership, location) and physician 
characteristics (e.g., gender, age, specialty). Please see the table at the end of this section 
for each of the NHIRD data files and the variables they provide for this study. Table 3.1 
shows the variables used for this study and their definitions. 
Registry for Tuberculosis Patients 
 The TCDC manages a registry for all TB patients. Registration for TB patients 
started in 1957, and the computerized National TB Register with a registration network 
was established in 1994. Information on TB patients is reported to the TCDC by health 
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care institutions. The data set provides some of the treatment outcomes for each TB 
patient, including TB treatment default and death. Following definitions from WHO, a 
negative sputum smear in the last month of treatment, being identified as cured on at least 




Table 3.1 Variables Used for the Study and Definitions 
NHIRD data files Description and Variables 
Registry for contracted medical 
facilities (HOSB) 
This file contains information on all health care 
facilities contracted with BNHI and can be linked 
to the TB patients’ ambulatory services claim 
data. It provides the following variables for this 
study: 
 Facility ID 
 Ownership 
 Accreditation level 
 Geographical location 
Registry for medical personnel 
(PER) 
The PER file consists of information for medical 
personnel who work for the contracted health 
care facilities. The following variables are 
available from this file: 
 Medical personnel ID 
 Physician gender 
 Physician birthday (used to calculate age) 
 Physician specialty 
Registry for beneficiaries (ID) This file contains information for BNHI 
beneficiaries. It provides the following variables 
for the study: 
 Beneficiary ID 
 Birthday (used to calculate age) 
 Gender 
 Insurance premium (a proxy for 
beneficiary’s socio-economic status) 
 Beneficiary’s work or residence location 
 Death  
Ambulatory care expenditures 
by visits (CD) 
This file contains information about a patient’s 
outpatient visits. The following variables will be 
used for the proposed study from the file: 
 Beneficiary ID 
 Facility ID 
 Medical personnel ID 
 Date of the visit 
 Diagnosis (ICD-9-CM, used to identify 
mood disorder and other co-morbid) 
 Disability 
TCDC TB Register data files Description and Variables 
Registry for TB patients This file contains information about a patient’s 
treatment outcome. The following variables will 
be used for the proposed study from the file: 
 Anti-TB medication start and end date,  
 Treatment interrupt date 
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3.3.3  Study Population  
Study Subjects 
 P4P on TB programs in Taiwan was implemented on November 2001 and ended at 
the end of 2007. Study subjects consist of newly developed TB cases from 2002 to 
December 2007. Cases with ICD-9-CM code 010–018 were included in this program, but 
multi-drug resistant tuberculosis (MDR-TB) cases, extra-pulmonary TB cases and 
atypical mycobacterium tuberculosis cases were excluded. 
3.3.4  Measures and Variables 
Dependent and Independent Variables: 
Default status 
 According to the TCDC’s and US CDC’s definitions, default status represents 
whether a TB patient’s treatment is interrupted for two months or longer. This variable is 
defined as a patient with a duration between two visits that is longer than two months or a 
patient who stops going to the TB medical visit before he/she completes the treatment. 
This variable is a binary variable, coded as 1 for either situation mentioned above, and 
coded as 0 if otherwise.  
Mortality 
 The variable comes from the record of NHIRD. We follow up enrolled patients 
from year 2002 to the end of 2010. Mortality is coded by 1 if a patient dies, and 0 
otherwise.  
Main Independent Variables 
Mood status  
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 A patient with mood disorder and anxiety was identified by using the ICD-9-CM 
code in the ambulatory and inpatient services claim file. If a patient had one or more 
outpatient visits or hospitalizations before TB is identified, or during the TB treatment 
period with the following ICD-9-CM code, he/she was identified as a patient with mood 
disorder and anxiety: bipolar: 296.0X–296.1X, 296.4X–296.8X; depressive disorder: 
296.2X–296.3X, 300.4, 311.X; anxiety: 300–300.3, 300.5, 300.7–300.9; or adjustment 
reaction: 309. Mood status is a dichotomous variable with 1 denoting the identification of 








Bipolar disorder 296.0, 296.1, 296.2, 296.3, 296.4, 296.5, 296.6, 296.8, 296.9 
Depressive disorder 296.20, 296.21, 296.22, 296.23, 296.24, 296.25, 296.26  
296.3, 300.4, 311 
Anxiety 300.1, 300.2, 300.3, 300.5, 300.7, 300.8, 300.9 
Adjustment reaction 309 
†





 The program was officially named "Pay-for-Performance on Tuberculosis" (P4P 
on TB). Hospitals in Taiwan could choose to participate in the P4P on TB program if 
they satisfied the eligibility criteria. This program operated from November 2001 to the 
end of 2007.  
Other covariates 
Patients characteristics covariates:  
Gender 
 Gender is a categorical variable with 1 indicating a male patient and 2 indicating a 
female patient. 
Age 
 Age is a numerical variable, calculated as the difference between the date TB is 
identified and the study subject’s birthday. 
Urbanization 
 Urbanization is a categorical variable. The urbanization level was categorized 
using information relating to population density of the residential area, population ratio of 
the elderly, agriculture workers, different educational levels, and the number of 
physicians per 100,000 people (Liu CY, 2006). We assumed that patients lived near the 
medical organizations they visited most frequently. Urbanization was classified into high 
and low categories. 
Disability  
 The government of Taiwan provides a premium subsidy to individuals with 
physical disabilities as a part of the welfare program. Therefore, we can identify an 
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individual’s physical disability status from the NHI enrollment file. Disability is defined 
as a binary variable. 
Insurance premium  
 This is a numeric variable, which is a proxy for the beneficiary’s socio-economic 
status since the premium is based on income (presented in new Taiwan dollars). 
Insurance premium are divided to three categories NTD < 15,000, NTD 15,000-19,999 
and ≧NTD 20,000.  
Charlson comorbidity index score   
 This variable was defined as the number of other medical diseases identified from 
outpatient and inpatient claim data files. Comorbidities were selected according to the 
Charlson Comorbidity Index (CCI), which is the most common medical comorbidity 
measure to assess medical comorbidity (Charlson, Pompei, Ales, & MacKenzie, 1987; 
Pirraglia, Biswas, Kilbourne, Fenn, & Bauer, 2009). These comorbidities represent the 
chronic medical condition of the patients. Levels of comorbidity are defined using a 
numerical label and weights of diseases: zero, 1, 2, 3 or greater than 3 diseases.  
 
Related risk co-morbidities 
 This variable investigates comorbidities that may be associated with mood 
disorder, which include the following: hypertension (ICD-9 codes 401–405), diabetes 
(ICD-9 code 250), hyperlipidemia (ICD-9 code 272), chronic kidney disease (CKD) 
(ICD-9 code 585), chronic liver disease and cirrhosis (CLD) (ICD-9 code 571), human 
immunodeficiency virus (HIV) disease (ICD-9 code 042) and schizophrenic disorders 
(ICD-9 code 295). 
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Hospital and physician characteristics covariates:  
Location of a health care facility 
 This is a categorical variable that represents the location of health care facilities 
caring for TB patients. This variable is used to adjust for differences in medical resources, 
practice patterns, and medical environments that may confound the association between 
independent variables and outcome variables in the analysis. The classification of this 
variable adopts the six branches identified by the BNHI, including the Taipei branch, 
Northern branch, Taichung branch, Southern branch, Kao-Pin branch, and Eastern branch. 
Accreditation level of a health care facility 
 This is a categorical variable which represents the contract category of the 
healthcare facility with the BNHI. The accreditation level of a healthcare facility is 
determined by a panel of experts during an on-site inspection of hospital size, capability, 
and quality of healthcare services. Accreditation for health facilities is divided into four 
categories, including medical centers, regional hospitals, district hospitals, and others 
(e.g., clinics). 
Ownership of a health care facility  
 This is a categorical variable that accounts for the ownership of the healthcare 
facility caring for TB patients. Categories for this variable include: public hospital, 
private religious hospital, or other private hospital.  
Physician gender 
 This is a categorical variable with 1 indicating a male physician and 2 indicating a 




 This is a numerical variable, calculated as the length of time in years between the 
study physician’s date of birth and the date when TB is identified in a patient. 
Physician specialty 
 This is a categorical variable that indicates the main licensed specialty of the 
physician. 
3.3.5  Statistical Analysis Plan 
Statistical Methods 
Descriptive Analysis 
 To answer research question 1 and 2, numbers, percentages will be used to 
quantify the prevalence of TB in patient with and without mood disorder. Patient 
characteristics will also be described. Chi-square test for categorical variables are used to 
test the differences in the outcome variables (e.g., default status, mortality) between TB 
patients with and without mood disorder, as well as other covariates.  
Moreover, differences in patient characteristics and outcome variables between 
subjects enrolled or not enrolled in the P4P on TB program are also be presented. The 
Chi-square test were also be used to test the significance of the differences. The table 
below describes how the results of the descriptive analysis will be presented.   
Multivariate Regression and Logistic Model  
 To further answer research question 2, I regress various patient characteristic 
variables on TB patient mood disorder status to assess what patient characteristics are 
associated with the presence of mood disorder. Odds ratios, their 95% confidence 
intervals, and p values will be presented. 
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To examine whether TB patients with mood disorder have the same treatment 
default as TB patients without mood disorder, different models will be fit to match the 
traits of the outcome variables. Outcome variables of default status will be analyzed using 
multivariate logistic models to allow for adjustment of other covariates and confounders.  
Cox Proportional Hazards Regression Models and Kaplan–Meier Method  
 The Kaplan–Meier method is used to estimate the survival rate and the log-rank 
test is used to examine the difference between the curves. By using univariable and 
multivariable Cox proportional hazards regression models, the relative hazard ratios (HRs) 
and the 95% confidence interval (CI) were calculated to examine the mortality of TB 
patients with and without mood disorder. The multivariable model controls for age, 
gender, income level, urbanization level and comorbidities with a significant difference 
in univariable Cox proportion hazards regression.  
To answer research questions 5 and 6 regarding the effect of P4P on TB programs, 
we assess all study subjects from 2002-2010. Interaction terms of TB patient mood 
disorder status, treatment, hospital participation status in the P4P program will be used to 
compare the differences in the outcomes between P4P and non-P4P participating sites, 
and between TB patients with mood disorder and without mood disorder .  
Random effects have considered and employed if there is medium to high levels 
of clustering among patients treated by the same physicians, the same health care facility, 
or in the same geographical area. Intra-class correlation coefficient (ICC) was used to 
report the magnitude of the clustering effect. Table 3.3 details the statistical analysis plan, 
including variables and statistical models proposed for each research question:  
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3.3.6  Internal Validity and External Validity 
 The most critical threat to the internal validity of this study is that hospitals 
volunteer to participate in the P4P on TB program, which makes the P4P on TB program 
participation not an extraneous variable (Shi, 1997). In our study, the data provided by 
NHIRD is reported by health care facilities and supervised by the BNHI. The TCDC TB 
registry data are collected by the TB management system. No interviews, questionnaires, 
or tests used in this study. Therefore, testing and instrumentation treatment factors will 
not influence the internal validity of this study. History may be a threat to the internal 
validity. However, a group of control hospitals that did not participate in the P4P on TB 
program is included as a reference group, which may minimize the history threat. 
The external validity of the study is relatively high because all TB patients will be 
observed and analyzed in the study. The study results are expected to reflect all of the TB 
patient population in Taiwan. However, the results may not be applicable to other 
geographic areas.  
 
3.3.7  Ethical consideration 
 This study had been submitted to the Institutional Review Board at the Johns 
Hopkins Bloomberg School of Public Health. The JHSPH IRB reviewed and gave 
officially approval with IRB No: 00004870 on January 11, 2013. We used secondary 
datasets--the NHIRD and TCDC TB registry file, to conduct this study. Both datasets are 
managed by the governmental agencies. The National Health Research Institutes (NHRI) 
and Taiwan’s Center for Disease Control (TCDC) encrypt and reconstruct the datasets 
before releasing the dataset to researchers. No personal identifiers will be included in any 
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of the datasets obtained. A pre-formatted agreement formulating the data use regulations 
of BNHI and NHRI and the Computer-Processed Personal Data Protection Act was 
signed between the researcher and the relevant government agencies. The researcher 




4. CHAPTER FOUR: RESULTS 
4.1  Study Aim 1:  
 To achieve the research aim 1) to investigate the prevalence and epidemiology of 
mood disorder, and examine patients' demographic characteristics and their relationship 
among TB patients in Taiwan, the research questions and hypotheses are: 
Researcher question 1: What is the prevalence of mood disorder among TB patients in 
Taiwan?  
Hypothesis 1: The prevalence of mood disorder is higher in TB patients than in the 
general population in Taiwan. 
Results: During the study period, a total of 5,327 patients with TB were enrolled, and 
1140 of the TB patients were diagnosed with mood disorder. The prevalence of mood 
disorder in years 2007 was 26.75% (796/2976). In the general population in Taiwan, the 
prevalence of mood disorder was 12.6% (111712/883453) in the same year. Thus, the 
prevalence of mood disorder in TB patients was two-fold higher than in the general 
population. The distribution of different types of mood disorder are listed in Table 4.1 
and the trend is presented in Figure 4.1. About 83.4% of TB patients with mood disorder 









Table 4.1 Distribution of different type mood disorder 
 N % 
Adjustment reaction 16 1.40 
Bipolar 353 3.07 
Depressive disorder 296 26.0 




Research question 2: Among TB patients, what patient characteristics are associated 
with the presence of mood disorder in Taiwan?  
Hypothesis 2 : Patient’s age, gender, socio-economic status, location of residence, 
disease severity, and other co-morbidities are associated with the presence of mood 
disorder among TB patients. 
Results: Table 4.2 shows that the comparison of mood status with TB patient 
characteristics and health status using logistic regression analysis. The results adjust for 
Charlson comorbidity index score (CCI) or comorbidities. The multivariable regression 
analysis indicates an increased risk of mood disorder in TB patients with the following 
characteristics: 
1. Older age: TB patients older than 65 years of age have a significantly higher risk of 
mood disorder (OR = 2.79, 95% CI = 2.28–3.42, P﹤0.001). There is also a trend of 
higher risk of having a mood disorder as age increases.   
2. Female: women with TB have a higher probability of having a mood disorder than men 
(OR = 1.8, 95% CI = 1.57–2.07, P﹤0.001). 
3. Higher income: TB patients with higher income have a greater probability of having a 
mood disorder than lower income patients (OR = 1.35, 95% CI = 1.10–1.65, P﹤0.01).  
4. Disability: TB patients with a disability have a higher risk of having a mood disorder 
than TB patients without a disability (OR = 1.70, 95% CI = 1.36–1.65, P﹤0.001). 
5. Comobidities: TB patients with a higher Charlson comorbidity index score (CCI) may 
have a significantly higher chance of having a mood disorder. TB patients had a higher 
risk of mood disorder in terms of the following comorbidities: hypertension (OR = 1.77, 
95% CI = 1.50–2.10, P﹤0.001), diabetes (OR = 1.32, 95% CI = 1.13–1.55, P﹤0.001), 
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CLD (chronic liver disease and cirrhosis) (OR = 1.90, 95% CI = 1.62–2.20, P﹤0.001), 
and hyperlipidemia (OR = 1.26, 95% CI = 1.07–1.50, P﹤0.01).  
6. Patients in P4P participated hospital have a higher risk of having mood disorder than in 
non-P4P participants (OR = 1.15, 95% CI = 1.00–1.32, P﹤0.05). 
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Table 4.2 Comparisons in the patients’ demographic characteristics and health status in TB with or without 







mood disorder  
N=1140 
(21.4%) 
 OR (95% CI) 
  N % N % p-value† Crude  Model 1†  Model 2†† 
P4P     0.01    
No  2671 63.8 680 59.6  1.00 1.00 1.00 








Age, year     <0.0001    
<45 1331 31.8 170 14.9  1.00 1.00 1.00 














Means (SD)         
Gender     <0.0001    







Male=1 2768 66.1 645 56.6  1.00 1.00 1.00 
Insurance premium 0.06    
< 15,000 1405 33.6 344 30.2  1.00 1.00 1.00 
NT$ 15,000-
19,999 














Urbanization      0.85    
High  2139 51.1 586 51.4  1.00 -- -- 
Low  2048 48.9 554 48.6  0.99 (0.87-1.13) -- -- 
Disability      <0.0001    
No  3891 92.9 991 86.9  1.00 1.00 1.00 







Charlson comorbidity index score <0.0001    
0 2743 65.5 590 51.8  1.00 1.00 -- 



















Baseline Comorbidities     
Hypertension      <0.0001    
No  2620 62.6 457 40.1  1.00 -- 1.00 
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Yes  1567 37.4 683 59.9  
2.50  
(2.19-2.86)*** 
-- 1.77  
(1.50-2.10)*** 
Diabetes      0.0005    
No  3388 80.9 869 76.2  1.00 -- 1.00 
Yes  799 19.1 271 23.8  
1.32  
(1.13-1.55)*** 
-- 0.80  
(0.67-0.95)* 
Hyperlipidemia      <0.0001    
No  3459 82.6 801 70.3  1.00 -- 1.00 
Yes  728 17.4 339 29.7  
2.01  
(1.73-2.34)*** 
-- 1.26  
(1.07-1.50)** 
CKD     0.003    
No  4032 96.3 1075 94.3  1.00 -- 1.00 





CLD     <0.0001    
No  3343 79.8 740 64.9  1.00 -- 1.00 
Yes  844 20.2 400 35.1  
2.14  
(1.86-2.47)*** 
-- 1.90  
(1.62-2.20)*** 
HIV infection      0.051    
No  4173 99.7 1140 100.0  1.00 -- -- 
Yes  14 0.33 0 0.00  -- -- -- 
Schizophrenia      0.95    
No  4162 99.4 1133 99.4  1.00 -- -- 





Hospital level     0.97    














Others 413 9.86 112 9.82  1.00 -- -- 
Hospital 
ownership 
    0.99    
Public 1611 38.5 439 38.5  1.00 -- -- 
Private 
religious 








Geographic location 0.09    
Taipei 975 23.3 261 22.9  1.00 -- -- 





















Age, year     0.67    
< 35 617 14.7 161 14.1  1.00 -- -- 








Gender     0.93    
Female=2  242 5.79 65 5.72  1.00 -- -- 




Specialty     0.70    
Chest Medicine 1757 42.0 487 42.7  1.00 -- -- 
Infectious 
Disease 


























†Chi-square test, t-test and logistic regression 
†Mode 1 was adjusted by patient characteristics , physician and practice characteristics,  P4P participation and 
Charlson comorbidity index score (CCI) ††Mode 2 was adjusted for patient characteristics , physician and practice 
characteristics,  P4P participation  and baseline comorbidities 




4.2   Study Aim 2: 
 To achieve research aim 2) to evaluate the impact of mood disorder on TB 
treatment default and P4P effect on TB patients, the research questions and hypotheses 
are: 
Research question 3: Do TB patients with mood disorder have the same rate of 
treatment default rate as TB patients without mood disorder in Taiwan? 
Hypothesis 3: TB patients with mood disorder have a higher default rate than TB 
patients without mood disorder in Taiwan.  
Results: 
Mood Disorder and Patient's Default  
 Patient characteristics and default 
 Table 4.3 presents the relationship of patients' default from TB treatment and 
associated factors in the logistic regression analysis. The default rates are based on 
patient characteristics (age, gender, SES, disability status, co-morbidity level and P4P 
participation), as well as physician and practice characteristics (physician age, gender, 
specialty, accreditation level of practice setting, ownership of the practice, and 
geographic area).Mood disorder TB patients had significant higher default than non-
mood disorder TB patients (OR=1.37, 95% CI 1.17 -1.59).. 
According to Table 4.4, the default rate from TB treatment varies based on patient 
characteristics. The crude odds ratio for the age factor for non- mood disorder patients 
younger than 45 years of age suggests a higher risk for default (47.6%, crude (OR=1.51, 
95% CI 1.30-1.74, p﹤0.001). However, after controlling for other patient characteristics, 
and physician and hospital characteristics, the odds ratio of for the ﹤45 years old group 
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was 1.14 (95% CI =0.94-1.37). Therefore, age of the patient seems to not have an effect 
on patients’ default from TB treatment. 
The odds ratio of default comparing females versus males in the mood disorder 
group, after considering confounding variables, was 1.38 (95% 1.05-1.81)(p﹤0.05). The 
non-mood disorder group has similar results (OR=1.66, 95% CI 1.43-1.92, p﹤0.001). 
Hence, female patients had significantly higher default rates than male patients in both 
the mood disorder and non-mood disorder group.     
Looking at patients' socio-economic variables by comparing insurance premiums, 
patients with the insurance premium NTD 15,000-19,999 had significantly less default 
rates than patients with the insurance premium ≧NTD 20,000 in the non-mood disorder 
group. However, there were no significant differences in the mood disorder group. There 
was also no difference in default rates between patients living in urban or rural areas in 
both mood disorder and non-mood disorder groups.    
Level of patients’ physical condition was determined by their disability and 
comorbidity. Higher CCI score represents more serious medical condition. Patients’ 
disability had no influence on their default from TB treatment. However, using CCI to 
identify the relationship between patient's comorbidity level and default rate, we see that 
higher CCI was associated with lower default from treatment in the non-mood disorder 
group, after adjusting for other variables. There was no difference in mood group.  
Hospital and physician characteristics with default  
 For accreditation level of practice setting, hospitals below the regional hospital 
level had a significantly higher default rate than medical centers in both mood disorder 
 
 57 
and non-mood disorder group. Private hospitals had lower default rate than public 
hospitals. Using Taipei as a reference city, hospitals located in Northern and in Eastern 
branch had lower default rate than Taipei. 
 For physician characteristics, physician age and gender had no effect in patient 
default. Family medicine doctors had significantly higher default rate (OR=2.66, 95% 
CI=1.06-6.71, P﹤0.05 in mood disorder; OR=1.70, 95% CI=1.11-2.59, P﹤0.05 in non-
mood disorder) than chest doctors. 






Table 4.3 Results of the impact of mood disorder on TB treatment default and associated risk factor among 
TB patients using logistic regression analysis 
 TB patients default OR (95% CI) 
  N %  Crude  Model 1  Model 2 
Patient characteristics 
Mood disorder      
No  1769 42.3 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Yes  540 47.4 1.23 (1.08-1.40)** 1.37 (1.17-1.59)*** 1.35 (1.16-1.57)*** 
P4P      
No  1937 57.9 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Yes  370 18.7 0.17 (0.15-0.19)*** 0.18 (0.16-0.21)*** 0.18 (0.16-0.21)*** 
Age, year      
<45 709 47.2 1.36 (1.19-1.55)*** 1.10 (0.93-1.30) 1.15 (0.96-1.37) 
45-65 678 45.1 1.25 (1.10-1.42)*** 1.15 (0.98-1.35) 1.22 (1.04-1.43)* 
>65 922 39.7 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Gender      
Female=2  989 51.7 1.70 (1.51-1.90)*** 1.59 (1.39-1.80)*** 1.59 (1.40-1.81)*** 
Male=1 1320 38.7 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Insurance premium 
< 15,000 793 45.3 1.23 (1.08-1.39)** 1.26 (1.09-1.45)** 1.25 (1.09-1.45)** 
NT$ 15,000-
19,999 
1024 40.4 1.00 (reference) 1.00 (reference) 1.00 (reference) 
>=NT$ 20,000 492 47.3 1.32 (1.15-1.530*** 1.31 (1.11-1.55)** 1.32 (1.11-1.56)** 
Urbanization       
High  1223 44.9 1.14 (1.02-1.27)* 1.04 (0.91-1.19) 1.06 (0.92-1.21) 
Low  1086 41.7 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Disability       
No  2116 43.3 1.00 (reference) -- -- 
Yes  193 43.4 1.00 (0.82-1.22) -- -- 
Charlson comorbidity index score 
0 1557 46.7 1.46 (1.22-1.73)*** 1.25 (1.02-1.54)* -- 
1  303 38.2 1.03 (0.83-1.27) 1.12 (0.88-1.42) -- 
2 196 37.1 0.98 (0.77-1.24) 0.96 (0.74-1.25) -- 
3+ 253 37.6 1.00 (reference) 1.00 (reference) -- 
Baseline Comorbidities  
Hypertension       
No  1386 45.0 1.00 (reference) -- 1.00 (reference) 
Yes  923 41.0 0.85 (0.76-0.95)** -- 1.06 (0.92-1.21) 
Diabetes       
No  1938 45.5 1.00 (reference) -- 1.00 (reference) 
Yes  371 34.7 0.64 (0.55-0.73)*** -- 0.72 (0.61-0.84)*** 
Hyperlipidemia       
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No  1837 43.1 1.00 (reference) -- -- 
Yes  472 44.2 1.05 (0.91-1.20) -- -- 
CKD      
No  2231 43.7 1.00 (reference) -- 1.00 (reference) 
Yes  78 35.5 0.71 (0.53-0.94)* -- 0.84 (0.61-1.15) 
CLD      
No  1781 43.6 1.00 (reference) -- -- 
Yes  528 42.4 0.95 (0.84-1.08) -- -- 
HIV infection       
No  2306 43.4 1.00 (reference) -- -- 
Yes  3 21.4 0.36 (0.10-1.28) -- -- 
Schizophrenia       
No  2291 43.3 1.00 (reference) -- -- 
Yes  18 56.3 1.69 (0.84-3.40) -- -- 
Hospital characteristics 
Hospital level      
Medical center 762 40.0 1.32 (1.15-1.51)*** 0.96 (0.81-1.12) 0.94 (0.80-1.11) 
District hospital 585 33.6 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Regional 
hospital 
625 53.9 2.30 (1.98-2.68)*** 1.57 (1.31-1.89)*** 1.57 (1.30-1.89)*** 
Others 337 64.2 3.54 (2.88-4.34)*** 1.34 (0.88-2.03) 1.39 (0.92-2.10) 
Hospital ownership    
Public 959 46.8 3.11 (2.51-3.86)*** 1.37 (1.19-1.57)*** 1.36 (1.18-1.57)*** 
Private 
religious 
1079 37.7 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Other private 271 65.3 1.45 (1.30-1.63)*** 1.94 (1.24-3.04)** 1.86 (1.19-2.92)** 
Geographic location 
Taipei 569 46.0 1.72 (1.33-2.34)*** 1.94 (1.42-2.64)*** 1.98 (1.45-2.69)*** 
Northern 234 34.7 1.07 (0.81-1.42) 1.08 (0.79-1.49) 1.10 (0.80-1.51) 
Central 436 41.4 1.43 (1.10-1.87)** 2.27 (1.68-3.07)*** 2.28 (1.68-3.08)*** 
Southern 404 44.4 1.61 (1.23-2.11)*** 1.49 (1.10-2.04)* 1.50 (1.10-2.04)* 
Kao-Ping 563 49.3 1.96 (1.51-2.55)*** 1.89 (1.40-2.54)*** 1.92 (1.43-2.58)*** 
Eastern 103 33.1 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Physician characteristics 
Age, year      
< 35 315 40.5 1.00 (reference) 1.00 (reference) 1.00 (reference) 
35-64 1962 43.7 1.14 (0.98-1.33) 1.05 (0.89-1.26) 1.05 (0.88-1.25) 
>= 65 32 56.1 1.88 (1.09-3.24)* 1.12 (0.61-2.06) 1.10 (0.60-2.04) 
Gender      
Female=2  120 39.1 1.00 (reference) -- -- 
Male=1 2183 43.6 1.20 (0.95-1.52) -- -- 
Specialty      
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Chest Medicine 750 33.4 1.54 (1.11-2.13)** 1.65 (1.16-2.34)** 1.65 (1.16-2.35)** 
Infectious 
Disease 
52 24.6 1.00 (reference) 1.00 (reference) 1.00 (reference) 
Family 
Medicine 
145 73.6 8.53 (5.46-13.3)*** 3.02 (1.83-4.97)*** 3.10 (1.88-5.11)*** 
Tuberculosis 
Specialist 
719 55.5 3.81 (2.74-5.31)*** 2.10 (1.46-3.04)*** 2.09 (1.45-3.02)*** 
General 
Medicine  
378 44.5 2.45 (1.75-3.45)*** 1.32 (0.90-1.93) 1.31 (0.90-1.92) 
  Other 265 50.0 3.06 (2.14-4.37)*** 1.45 (0.98-2.16) 1.45 (0.98-2.15) 
†Chi-square, logistic regression analysis 
Mode 1 adjusted for patient characteristics , physician and practice characteristics,  P4P participation and  
Charlson comorbidity index score (CCI) ††Mode 2 adjusted for characteristics , physician and practice 
characteristics, P4P participation and baseline comorbidities 




Table 4.4 Results of comparing TB with and without mood disorder patients default from treatment and 
associated risk factor using logistic regression analysis 
 
 
TB patients with mood disorder  TB patients without mood disorder  
  N % Crude  Model†  N % Crude Model†  
P4P         
No 430 63.2 1.00 1.00 1509 56.5 1.00 1.00 










All  540 47.4   1769 42.3   
Patient characteristics 
Age, year         




















>= 65 284 45.4 1.00 1.00 638 37.6 1.00  
Gender (male vs. female) 










Male  281 43.6 1.00 1.00 1039 37.5 1.00 1.00 
Insurance premium (NT$) 
< 15,000 174 50.6 
0.97 
(0.69-1.36) 















>= 20,000 113 51.4 1.00 -- 379 46.2 1.00 1.00 
Urbanization          
High  291 49.7 
1.21 
 (0.96-1.53) 




Low  249 45.0 1.00 -- 837 40.9 1.00 -- 
Disability         
No  472 47.6 1.00 -- 1644 42.3 1.00 -- 
Yes  68 45.6 
0.92  
(0.65-1.30) 




Charlson comorbidity index score 
0 297 50.3 1.00 1.00 1260 45.9 1.00 1.00 






























Hospital characteristics  
Hospital level         
Medical 
center 





































Hospital ownership      























Geographic location  
Taipei  144 55.2 1.00 1.00 425 43.6 1.00 1.00 



















































Age, year         
< 35 60 37.3 1.00 1.00 255 41.3 1.00 -- 


















Gender          
Female  25 38.5 1.00 -- 95 39.3 1.00 -- 
Male  513 47.9 
1.47 
(0.88-2.46) 




Specialty         
Chest 
Medicine 















































Model† adjusted odds ratio: multivariable analysis including patient characteristics (age, gender, SES, disability 
status, co-morbidity level and P4P participation), physician and practice characteristics (physician age, gender, 
specialty, accreditation level of practice setting, ownership of the practice, and geographic area). 
* p<0.05, ** p<0.01, ***p<0.001 
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 Table 4.5 Results of logistic regression analysis with TB patients default from treatment 
stratified by patient, Hospital, and Physician characteristics 
 
 
TB patients with mood disorder  TB patients without mood disorder  
  Non-P4P P4P  Non-P4P P4P  
 N % 
Event 
no 
% Model  N % 
Event 
no 
% Model  
Patient characteristics 
Age, year           
< 45 62 57.9 14 22.2 
0.16 
(0.07-0.38)*** 
550 60.7 83 19.5 
0.17  
(0.13-0.24)*** 
45-64 149 69.3 31 23.9 
0.09  
(0.05-0.17)*** 
427 57.3 71 17.2 
0.14  
(0.10-0.20)*** 
>= 65 219 61.2 65 24.3 
0.26  
(0.18-0.39)*** 
532 52.2 1006 15.6 
0.20  
(0.16-0.26)*** 
Gender(male vs. female) 
Female  209 67.4 50 27.0 
0.15  
(0.10-0.25)*** 
644 66.6 86 19.0 
0.12  
(0.09-0.16)*** 
Male  221 59.7 60 21.8 
0.24  
(0.16-0.36)*** 
865 50.8 174 16.4 
0.21  
(0.17-0.26)*** 
Insurance premium (NT$) 
< 15,000 138 64.5 36 27.7 
0.24  
(0.14-0.41)*** 





196 60.1 57 22.8 
0.22  
(0.14-0.34)*** 
657 53.2 114 15.7 
0.18  
(0.14-0.23)*** 
>= 20,000 96 68.6 17 21.3 
0.08  
(0.03-0.18)*** 
622 61.3 57 19.3 
0.13  
(0.09-0.20)*** 
Urbanization            
High  229 63.6 62 27.4 
0.18  
(0.12-0.28)*** 
786 56.9 146 19.3 
0.18  
(0.14-0.23)*** 
Low  201 62.8 48 20.5 
0.20  
(0.13-0.31)*** 
723 56.1 114 15.0 
0.16  
(0.13-0.21)*** 
Disability           
No  376 63.6 96 24.0 
0.19 
(0.14-0.26)*** 
1403 56.6 241 17.1 
0.18  
(0.15-0.21)*** 
Yes  54 60.7 14 23.3 
0.30 
(0.11-0.85)* 
106 55.8 19 17.9 
0.16 
(0.08-0.31)*** 
Charlson comorbidity index score 
0 250 67.2 47 21.6 
0.14 
(0.09-0.22)*** 
1096 59.9 164 17.9 
0.15  
(0.12-0.19)*** 
1 57 53.3 29 26.9 
0.33  
(0.16-0.68)** 
171 51.4 46 18.8 
0.25  
(0.16-0.40)*** 
2 59 59.6 16 27.1 
0.14  
(0.05-0.38)*** 
101 46.5 20 13.1 
0.14  
(0.08-0.27)*** 
3+ 64 62.8 18 24.0 
0.25 
(0.10-0.59)** 
141 48.3 30 14.7 
0.21 
(0.12-0.36)*** 
Hospital characteristics  
Hospital level           
Medical 
center 
126 54.1 44 26.2 
0.31  
(0.18-0.53)*** 





99 57.9 42 20.3 
0.20 
(0.12-0.34)*** 





128 71.1 20 29.0 
0.15  
(0.08-0.30)*** 
437 62.3 40 19.1 
0.13 
(0.09-0.20)*** 




Hospital ownership       
Public 169 66.5 60 32.4 
0.25  
(0.16-0.40)*** 





198 56.7 47 17.9 
0.17  
(0.11-0.26)*** 
696 49.2 138 16.5 
0.21  
(0.17-0.27)*** 
Other  63 81.8 3 23.1 
0.16  
(0.02-1.32) 
201 77.0 4 6.25 
0.03  
(0.01-0.10)*** 
Geographic location  
Taipei  108 68.4 36 35.0 
0.19  
(0.10-0.36)*** 
359 58.3 66 18.4 
0.16 
(0.11-0.22)*** 
Northern 41 47.1 10 23.3 
0.65  
(0.21-1.99) 
150 43.6 33 16.4 
0.37 
(0.22-0.63)*** 
Central 96 70.1 24 19.8 
0.11  
(0.06-0.22)*** 
245 62.8 71 17.6 
0.16 
(0.11-0.24)*** 
Southern 81 70.4 15 19.0 
0.13  
(0.06-0.30)*** 
271 57.5 37 15.0 
0.15 
(0.10-0.23)*** 
Kao-Ping 88 59.9 16 19.8 
0.22  
(0.10-0.49)*** 
419 60.6 40 17.9 
0.15 
(0.10-0.23)*** 
Eastern 16 44.4 9 27.3 
0.32  
(0.03-3.01) 




Age, year           
< 35 47 50.0 13 19.4 
0.42  
(0.16-1.06) 
223 54.1 32 15.6 
0.1 
(0.10-0.27)*** 
35-64 376 65.1 97 24.8 
0.18 
(0.13-0.25)*** 
1261 56.6 228 17.6 
0.18  
(0.15-0.21)*** 
>=65 7 87.5 0 0.00 -- 25 810.7 0 0.00 -- 
Gender            
Female  17 53.1 8 24.2 
0.15  
(0.02-1.24) 
82 59.0 13 12.6 
0.09 
(0.04-0.24)*** 
Male  411 63.7 102 23.9 
0.19  
(0.14-0.26)*** 
1423 56.3 247 17.5 
0.18  
(0.15-0.21)*** 
Specialty           
Chest 
Medicine 
120 58.3 62 22.1 
0.21  
(0.14-0.33)*** 





3 23.1 12 36.4 
1.13 
(0.06-22.5) 





32 84.2 1 50.0 -- 112 76.2 0 0.00 -- 
General 
Medicine  
70 58.8 21 36.8 
0.39 
(0.18-0.86)* 
2045 50.9 42 21.9 
0.30  
(0.20-0.46)*** 
  Other 55 64.0 3 20.0 
0.07 
(0.01-0.51)** 
201 53.7 6 10.9 
0.08 
(0.03-0.20)*** 
†Mode 1 was adjusted by patient characteristics , physician and practice characteristics and Charlson comorbidity 
index score (CCI)  




Research question4: Do TB patients with mood disorder have the same mortality as TB 
patients without mood disorder in Taiwan?  
Hypothesis 4: TB patients with mood disorder have a higher mortality rate than TB 
patients without mood disorder in Taiwan. 
Results: 
Mortality of TB patients with mood disorder 
 To investigate the mortality of TB patients with mood disorder, Cox proportional 
hazard models were used to identify associated risk factors, the effect of P4P enrollment, 
and the overall survival of TB patients with mood disorder. In this study, we traced the 
mortality of enrollees from the year 2002 to the end of 2010. In the nine-year period, 376 
(33%) TB patients with mood disorder died, while 1232 (29.4)% TB patients without 
mood disorder died. Thus the all-cause mortality rate of TB patients with mood disorder 
was higher than that of non-mood disorder patients. The Kaplan–Meier survival analysis 
showed that the survival rate was lower in TB patients with mood disorder than in the 
non-mood disorder patients (log-rank test p ﹤0.05). Time series tables and survival 
curves containing detailed descriptions of time to event (death) can be found in Figure 
4.2. The log-rank test indicates that TB patients with mood disorder had significantly 









The mortality of TB patients  
 We examined the mortality of TB enrollees from the year 2002 to the end of 2010. 
Table 4.6 and 4.7 present patient mortality data and related risk factors for patients with 
only TB, using Cox proportional hazards regression model. Regarding TB patients' 
demographic factors, we did find a trend of increased number, proportion, or hazard 
ratios of deaths in the elderly, male, low income, disabled, or those with different CCI 
scores. After adjustment, patients older than 65 years of age had a greater risk (8.47 times) 
of mortality than patients younger than 45 years of age (HR=8.47, 95% CI = 6.79–10.6, P
﹤0.001). Patients with higher CCI scores also had a significantly higher hazard ratio 
than patients with a CCI score of zero (HR=4.7, 95% CI = 4.09–5.39, P﹤0.001). The 
comorbidities of hypertension, diabetes, and chronic kidney disease contributed to a 
significantly high risk of death. There were no significant differences in mortality rate by 
hospital accreditation level. Private hospitals has lower mortality than public hospitals 
( HR=0.88, 95% CI = 0.79–0.99, P﹤0.05). Hospitals located in southern and Kao-ping 
branch had higher mortality rates than hospitals in Taipei (in southern HR=1.27, 95% CI 
= 1.06–1.52, P﹤0.01; in Kao-ping HR=1.18, 95% CI = 1.00–1.38, P﹤0.05). TB patients 
with male physicians had higher mortality rates  than TB patients with female 
physicians. Infectious disease physicians had significantly higher risk of patient mortality 
than other specialties. It may be that TB patients in the infectious disease department had 
more complex conditions.  
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Table 4.6 Mortality and associated risk factor in TB patients using Cox proportional hazard 
regression 
 
  HR (95% CI) 
  N % Crude  Model 1  Model 2 
Patient characteristics 
Mood disorder      
No  1232 61.69 1.00 1.00 1.00 
Yes  376 72.57 1.16 (1.03-1.30)* 1.80 (1.61-1.90)*** 1.84 (1.70-1.95)** 
P4P      
No  1013 60.05 1.00 1.00 1.00 
Yes  595 71.84 1.11 (1.01-1.23)* 0.93 (0.83-1.05) 0.96 (0.86-1.08) 
Age, year      
<45 97 11.41 1.00 1.00 1.00 
45-65 287 36.63 3.16 (2.51-3.98)*** 2.45 (1.94-3.09)*** 2.89 (2.28-3.66)*** 
>65 1224 138.81 11.4 (9.23-14.0)*** 6.03 (4.85-7.49)*** 8.47 (6.79-10.6)*** 
Gender      
Female=2  422 44.80 1.00 1.00 1.00 
Male=1 1186 75.40 1.66 (1.49-1.86)*** 1.28 (1.15-1.44)*** 1.34 (1.20-1.50)*** 
Insurance premium 
< 15,000 651 83.50 2.75 (2.32-3.26)*** 1.61 (1.34-1.92)*** 1.80 (1.51-2.16)*** 
NT$ 15,000-
19,999 
794 67.21 2.23 (1.88-2.64)*** 1.35 (1.13-1.61)*** 1.43 (1.20-1.70)*** 
>=NT$ 20,000 163 29.42 1.00 1.00 1.00 
Urbanization       
High  737 56.01 1.00 1.00 1.00 
Low  871 72.63 1.28 (1.16-1.41)*** 0.98 (0.87-1.09) 1.07 (0.96-1.19) 
Disability       
No  1370 58.14 1.00 1.00 1.00 
Yes  238 149.96 2.43 (2.11-2.78)*** 1.45 (1.26-1.68)*** 1.91 (1.66-2.21)*** 
Charlson comorbidity index score 
0 487 26.99 1.00 1.00 -- 
1  339 100.17 3.58 (3.11-4.11)*** 2.18 (1.88-2.51)*** -- 
2 289 148.83 5.21 (4.51-6.03)*** 3.03 (2.60-3.53)*** -- 
3+ 493 276.89 9.11 (8.03-10.3)*** 4.70 (4.09-5.39)*** -- 
Baseline Comorbidities  
Hypertension       
No  598 37.45 1.00 -- 1.00 
Yes  1010 109.97 2.80 (2.53-3.10)*** -- 1.15 (1.02-1.29)* 
Diabetes       
No  1139 54.69 1.00 -- 1.00 
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Yes  469 108.43 1.90 (1.70-2.11)*** -- 1.26 (1.12-1.41)*** 
Hyperlipidemia       
No  1287 63.71 1.00 -- -- 
Yes  321 64.85 1.01 (0.89-1.14) -- -- 
CKD      
No  1479 60.56 1.00 -- 1.00 
Yes  129 177.48 2.68 (2.24-3.21)*** -- 1.43 (1.19-1.73)*** 
CLD      
No  1169 60.06 1.00 -- 1.00 
Yes  439 77.20 1.27 (1.14-1.42)*** -- 1.02 (0.91-1.14) 
HIV infection       
No  1604 63.93 1.00 -- -- 
Yes  4 65.72 1.00 (0.38-2.67) -- -- 
Schizophrenia       
No  1603 64.28 1.00 -- 1.00 
Yes  5 23.38 0.40 (0.17-0.97)* -- 0.67 (0.27-1.61) 
Hospital characteristics 
Hospital level      
Medical center 594 65.37 1.00 1.00 1.00 
District hospital 523 65.91 0.99 (0.88-1.11) 1.11 (0.97-1.26) 1.07 (0.94-1.22) 
Regional 
hospital 
388 72.96 1.11 (0.98-1.26) 1.10 (0.94-1.28) 1.09 (0.93-1.27) 
Others 103 36.64 0.58 (0.47-0.71)*** 0.98 (0.66-1.45) 0.73 (0.49-1.07) 
Hospital ownership   
Public 78 35.64 1.00 1.00 1.00 
Private 
religious 
835 61.36 0.83 (0.75-0.92)*** 0.94 (0.84-1.06) 0.88 (0.79-0.99)* 
Other private 695 74.30 0.49 (0.39-0.62)*** 0.73 (0.49-1.11) 0.86 (0.57-1.31) 
Geographic location 
Taipei 332 53.53 1.00 1.00 1.00 
Northern 161 50.01 0.91 (0.75-1.10) 0.97 (0.80-1.19) 1.07 (0.88-1.31) 
Central 326 67.24 1.22 (1.05-1.42)* 1.08 (0.91-1.29) 1.18 (0.99-1.41) 
Southern 351 87.90 1.59 (1.37-1.85)*** 1.14 (0.96-1.37) 1.27 (1.06-1.52)** 
Kao-Ping 354 66.67 1.22 (1.05-1.41)* 1.08 (0.92-1.26) 1.18 (1.00-1.38)* 
Eastern 84 53.25 0.99 (0.78-1.26) 0.97 (0.75-1.25) 1.08 (0.83-1.40) 
Physician characteristics 
Age, year      
< 35 236 65.11 1.00 1.00 1.00 
35-64 1365 64.47 0.99 (0.87-1.14) 1.05 (0.91-1.22) 1.05 (0.91-1.21) 
>= 65 7 19.80 0.33 (0.16-0.69)** 0.51 (0.24-1.10) 0.52 (0.24-1.12) 
Gender      
Female=2  556 37.24 1.00 1.00 1.00 
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Male=1 1547 65.47 1.76 (1.35-2.30)*** 1.40 (1.06-1.84)* 1.49 (1.13-1.96)** 
Specialty      
Chest Medicine 642 63.10 1.00 1.00 1.00 
Infectious 
Disease 
74 83.61 1.30 (1.03-1.66)* 1.32 (1.04-1.69)* 1.50 (1.18-1.91)** 
Family 
Medicine 
44 45.64 0.74 (0.55-1.01) 1.07 (0.76-1.50) 1.02 (0.73-1.43) 
Tuberculosis 
Specialist 
438 71.97 1.17 (1.04-1.32)* 1.12 (0.96-1.30) 1.09 (0.94-1.26) 
General 
Medicine  
271 65.50 1.07 (0.93-1.23) 1.15 (0.98-1.34) 1.21 (1.03-1.42)* 
  Other 139 47.88 0.81 (0.67-0.97)* 0.91 (0.74-1.11) 0.95 (0.77-1.16) 
†Chi-square test, t-test and Cox proportional hazards regression  
Mode 1 adjusted for patient characteristics , physician and practice characteristics,  P4P participation and  
Charlson comorbidity index score (CCI) ††Mode 2 adjusted for characteristics , physician and practice 
characteristics, P4P participation and baseline comorbidities 
⁎ p﹤0.05, ⁎⁎ p ﹤0.01, ⁎⁎⁎ p ﹤0.001. 




We further explored the influence of mood disorder on TB patients’ mortality. Table 
4.7 shows mortality rates for TB patients with mood disorder and associated risk factors. 
Using the multivariable Cox proportional hazards regression model, we found an 
increased risk of mortality in TB patients with mood disorder patients with the following 
characteristics:  
1. Older age: TB patients who were older than 65 years of age had significantly 
higher risk of death regardless of mood disorder status (HR=3.82, 95% CI=2.28–6.42, P
﹤0.001; HR=6.60, 95% CI=5.19–8.38, P﹤0.001 ). There was a trend of higher risk of 
death with increased age.  
2. Male: both men with and without mood disorder had a higher risk of death than 
women (HR=1.68, 95% CI=1.35–2.09, P﹤0.001; HR=1.29, 95% CI=1.13–1.48, P﹤
0.001 ). 
3. Lower income: lower income patients had higher mortality rates in both mood 
disorder and non-mood disorder groups. (HR= 1.80, 95% CI = 1.22–2.66, P﹤0.01; HR= 
1.55, 95% CI = 1.27–1.90, P﹤0.001).  
4. Disability: TB patients with a disability had higher risk of death than TB patients 
without a disability in both mood disorder and non-mood disorder groups (HR = 1.44, 
95% CI = 1.11–1.88, P﹤0.01; HR = 1.41, 95% CI = 1.19–1.67, P﹤0.01). 
5. Commodity level: patients with higher the CCI score had a higher risk of 
mortality. 
6. Gender of physician: male doctors had patients with higher mortality rates than 
female doctors in the non-mood disorder group . 
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7. Specialty of physician: Specialized infectious disease physicians and general 




Table 4.7 The hazard ratio and 95% CI for all-cause mortality and associated risk factors in Cox 
proportional hazard regression ( 2002 - 2010) 
 
 
TB patients with mood disorder  TB patients without mood disorder  
  N %   
Crude HR 
(95% CI) 




P4P         
No 225 67.81 1.00 1.00 788 58.15 1.00 1.00 










All  376 72.57   1232 61.69   
Patient characteristics 
Age, year         
< 45 16 16.47 1.00 1.00 81 10.76 1.00 1.00 




















Gender (male vs. female) 
Female  120 52.36 1.00 1.00 302 42.36 1.00 1.00 










Insurance premium (NT$) 






















>= 20,000 35 29.86 1.00 1.00 128 29.31 1.00 1.00 
Urbanization          
High  184 67.48 1.00 -- 553 53.01 1.00 1.00 









Disability         
No  304 65.80 1.00 1.00 1066 56.27 1.00 1.00 










Charlson comorbidity index score 
0 94 30.38 1.00 1.00 393 26.29 1.00 1.00 






























Hospital characteristics  
Hospital level         
Medical 
center 





































Hospital ownership      





















Geographic location  
Taipei  79 62.42 1.00 -- 253 51.25 1.00 1.00 














































Age, year         
< 35 64 93.12 1.00 -- 172 58.56 1.00 1.00 


















Gender          
Female  15 48.04 1.00 -- 41 34.41 1.00 1.00 









Specialty         
Chest 
Medicine 
162 77.4 1.00 
-- 






















































Rate, per 1000 person-years; † Cox proportional hazards regression  
†Mode adjusted for patient characteristics, physician and practice characteristics, P4P participation and Charlson 
comorbidity index score (CCI) ⁎ p﹤0.05, ⁎⁎ p ﹤0.01, ⁎⁎⁎ p ﹤0.001.   
Rate, per 1000 person years 
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4.3  Study aim 3: 
To achieve research aim 3) to examine the impact of P4P effect on TB treatment default 
and TB patients’ mortality. the research questions and hypotheses are: 
Research question 5: Does P4P with the TB program improve TB  treatment default 
rate among TB with mood disorder patients ? 
Hypothesis 5: TB patients with mood disorder enrolled in the P4P program have a higher 
default rate than those patients who are not enrolled in the P4P program in Taiwan. 
Results: 
The participation condition of P4P on TB program 
 The patient characteristics of P4P on TB participants  
Table 4.8 lists comparisons of TB patients’ characteristics and health status between P4P 
and Non-P4P groups by mood disorder status. A total of 5,327 tuberculosis patients were 
included in this study. Of these patients, 1140 patients had a mood disorder and 4187 TB 
patients did not have a mood disorder. In the mood disorder group, 460 were P4P 
enrollees (40.3%). The non-mood disorder group had less P4P participation rate (36.2%).  
Age influences intention to participate in the P4P program (P﹤0.0001). The 
mean age of TB patients in the mood disorder group was 64.8 years old, which was older 
than the age of TB patients in the non-mood disorder group (57.9 years old). Patients 
over 65 years of age accounted for more than half of the mood disorder patients (58%). In 
both groups, the majority of participants were older (﹥65 years), and were more likely to 
participate P4P on TB program.  
In terms of gender, there were more male P4P participants than female. Males 
without a mood disorder were more likely to participate in the P4P program than females 
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(P﹤0.0001). The insurance premium and urbanization factors had no significant effect 
on the patients' intention to participate in P4P.  
More patients in the mood disorder group had a disability (13%) than patients in the non-
mood disorder group (6.99%). In both groups, most of P4P participants had no 
comorbidity, especially in the non-mood disorder group. Patients with no comorbidity 
(Charlson comorbidity index score CCI=0 ) were more likely to enroll in the P4P on TB 
program (P﹤0.0001).  
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Table 4.8 Comparison of TB patients’ characteristics and health status between P4P and Non-P4P by mood 
disorder 
 



















  n % n % p-value n % n % p-value 
Patient characteristics 
Age, year     0.20     <0.0001 
<45 107 15.7 63 13.7  906 33.9 425 28.0  
45-65 215 31.6 130 28.3  745 27.9 413 27.2  
>65 358 52.7 267 58.0  1020 38.2 678 44.7  
Means (SD) 63.0 
(16.
8) 
64.8 (15.7) 0.07 54.5 (21.7) 57.9 (20.2) <0.0001 
Gender     0.07     <0.0001 
Female 310 45.6 185 40.2  967 36.2 452 29.8  
Male 370 54.4 275 59.8  1704 63.8 1064 70.2  
Insurance premium 0.10     0.54 
< 15,000 214 31.5 130 28.3  911 34.1 494 32.6  
NT$ 15,000-
19,999 
326 47.9 250 54.4  1235 46.2 726 47.9  
>=NT$ 
20,000 
140 20.6 80 17.4  525 19.7 296 19.5  
Urbanization      0.21     0.29 
High  360 52.9 226 49.1  1381 51.7 758 50.0  
Low  320 47.1 234 50.9  1290 48.3 758 50.0  
Disability  89 13.1 60 13.0 0.98 190 7.11 106 6.99 0.88 
Charlson comorbidity index score 0.006     <0.0001 
0 372 54.7 218 47.4  1829 68.5 914 60.3  
1  107 15.7 108 23.5  333 12.5 245 16.2  
2 99 14.6 59 12.8  217 8.12 153 10.1  
3+ 102 15.0 75 16.3  292 10.9 204 13.5  
Chi-square test, t-test 
* p<0.05, ** p<0.01, ***p<0.001 
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The physician and health care facility characteristics of P4P on TB participants  
Hospital characteristics 
 Table 4.9 presents the distribution of physician and health care facility characteristics 
for patient P4P participation. Hospitals have a significantly different P4P participation 
level (P﹤0.0001). The majority of participants were from district level hospitals (44.5%) 
and medical center level hospitals (36.5%). District level hospitals were the main health 
care provider for TB patients. Private hospitals were also more likely to participate in the 
P4P program (59.2%, P﹤0.0001). The distribution of P4P participation by hospital 
geographic location was fairly average. But central Taiwan had a higher P4P 
participation rate than other areas, and the eastern Taiwan had lower participation.  
 
Physician characteristics  
The majority of physicians providing care for the TB patients were aged 35 to 64 years 
(85%) and male (93%). Physicians' specialty had a significant effect on P4P participation 
(P﹤0.0001). Physicians with a specialty in chest medicine were more likely to have 
patients to enrolled in the P4P program.  
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Table 4.9 Comparison the TB patients’ hospital and physician characteristics between P4P and non-P4P by 
mood disorder 
 



















  n % n % p-value n % n % p-value 
Hospital characteristics           
Hospital level     <0.0001     <0.0001 
Medical center 333 34.3 168 36.5  948 35.5 554 36.5  
District hospital 171 25.2 207 45.0  687 25.7 674 44.5  
Regional hospital 180 26.5 69 15.0  701 26.2 210 13.9  
Others 96 14.1 16 3.48  335 12.5 78 5.15  
Hospital ownership     <0.0001     <0.0001 
Public 254 37.4 185 40.2  995 37.3 616 40.6  
Private religious 349 51.3 262 57.0  1415 53.0 836 55.2  
Other private 77 11.3 13 2.83  261 9.77 64 4.22  
Geographic location     0.045     <0.0001 
Taipei 158 23.2 103 22.4  616 23.1 359 23.7  
Northern 87 12.8 43 9.35  344 12.9 201 13.3  
Central 137 20.2 121 26.3  390 14.6 404 26.7  
Southern 115 16.9 79 17.2  471 17.6 246 16.2  
Kao-Ping 147 21.6 81 17.6  691 25.9 223 14.7  
Eastern 36 5.29 33 7.17  159 5.95 83 5.47  
Physician characteristics           
Age, year     0.40     0.23 
< 35 94 13.8 67 14.6  412 15.4 205 13.5  
35-64 578 85.0 391 85.0  2228 83.4 1295 85.4  
>= 65 8 1.18 2 0.43  31 1.16 16 1.06  
Gender     0.08     0.04 
Female=2  32 4.73 33 7.17  139 5.21 103 6.79  
Male=1 645 95.3 427 92.8  2528 94.8 1413 93.2  
Specialty     <0.0001     <0.0001 
Chest Medicine 206 30.3 281 61.1  771 28.9 986 65.0  
Infectious Disease 13 1.91 33 7.17  86 3.22 79 5.21  
Family Medicine 38 5.59 2 0.43  147 5.50 10 0.66  
Tuberculosis Specialist 218 32.1 72 15.7  812 30.4 194 12.8  
General Medicine  119 17.5 57 12.4  481 18.0 192 12.7  
  Other 86 12.7 15 3.25  374 14.0 55 3.63  
Chi-square test, Fisher’s exact test and t-test 
* p<0.05, ** p<0.01, ***p<0.001 
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The influence of P4P participation on patient's default 
From Table 4.3, patients enrolled in P4P on TB programs had significantly lower default 
rates in both those with and without mood disorder (OR = 0.20, 95% CI = 0.15–0.26, P﹤
0.001 in the mood disorder group; OR = 0.16, 95% CI = 0.14–0.19, P﹤0.001 in non-
mood disorder group). Although both groups had a decreased default rate from TB 
treatment after P4P participation, comparing the total default rate between mood disorder 
and non-mood disorder groups shows that the default rate of patients with mood disorder 
is still higher than that of patients without mood disorder.. In the Table 4.4, we examined 
the influence of P4P participation on patient's default among the mood disorder and non-
mood disorder group. We stratified these two groups by patient, hospital and physician 
characteristics. Logistic regression was used to examine the effect of P4P on TB program. 
TB treatment defaults were significantly decreased in P4P participants based on patient's 
age, gender, income status, and comorbidity levels in both patients with or without mood 
disorder. 
Research question 6: Does P4P with TB program improve mortality among TB with 
mood disorder patients.  
Hypothesis 6: TB patients with mood disorder enrolled in the P4P program will have a 
lower mortality rate than those patients who are not enrolled in the P4P program in 
Taiwan. 
Results: 
Mortality of P4P on TB patients with mood disorder 




Table 4.10 Hazard ratio and 95% CI for P4P effect on mortality stratified by patient, hospital, and 
physician characteristics using multivariable Cox proportional hazard regression 
 
 
TB patients with mood disorder  TB patients without mood disorder  
  Non-P4P P4P  Non-P4P P4P  
 n %   n %   Model  n % n % Model  
Patient characteristics 
Age, year           
< 45 9 13.73 7 22.13 1.94 (0.62-6.07) 52 9.72 29 13.32 1.30 (0.78-2.19) 
45-64 40 35.06 25 43.27 0.87 (0.51-1.48) 143 33.96 79 41.47 1.17 (0.85-1.60) 
>= 65 176 115.65 119 122.83 0.93 (0.72-1.19) 593 148.63 336 143.77 0.86 (0.74-1.01) 
Gender (male vs. female) 
Female  67 43.38 53 70.91 1.16 (0.79-1.72) 215 42.43 87 42.20 0.77 (0.58-1.01) 
Male  158 89.09 98 87.86 0.87 (0.66-1.14) 573 67.55 357 81.92 0.98 (0.84-1.15) 
Insurance premium (NT$) 
< 15,000 95 99.60 60 121.90 1.12 (0.79-1.56) 319 72.48 177 90.80 0.97 (0.79-1.20) 
15,000-
19,999 
106 67.72 80 80.19 
0.90 (0.65-1.25) 
387 62.65 221 71.89 0.94 (0.78-1.14) 
>= 20,000 24 30.04 11 29.48 0.68 (0.31-1.50) 82 27.59 46 32.95 0.75 (0.49-1.14) 
Urbanization            
High  116 65.65 68 70.85 0.92 (0.67-1.26) 365 51.03 188 57.33 0.87 (0.71-1.07) 
Low  109 70.27 83 91.90 0.96 (0.70-1.33) 423 66.13 256 81.52 1.00 (0.84-1.20) 
Disability           
No  179 60.30 125 75.69 1.03 (0.80-1.31) 679 52.74 387 63.75 0.95 (0.82-1.09) 
Yes  46 131.52 26 122.98 0.69 (0.40-1.16) 109 161.02 57 163.34 0.80 (0.53-1.19) 
Charlson comorbidity index score 
0 58 27.67 36 36.06 1.00 (0.64-1.55) 266 25.19 127 28.94 1.07 (0.84-1.36) 
1 45 89.07 36 84.60 0.82 (0.51-1.32) 164 114.08 94 92.53 0.78 (0.59-1.04) 
2 49 115.47 27 114.72 1.05 (0.63-1.74) 125 151.86 88 191.74 1.16 (0.84-1.60) 
3+ 73 249.59 52 255.24 
0.98 (0.66-1.46) 
233 320.10 135 242.65 
0.76 (0.59-
0.97)* 
Hospital characteristics  
Hospital level           
Medical 
center 
86 73.52 55 81.25 1.04 (0.73-1.47) 284 56.89 169 75.20 1.00 (0.79-1.26) 
District 
hospital 
53 66.32 72 87.49 0.87 (0.60-1.28) 202 59.35 196 67.36 0.89 (0.71-1.11) 
Regional 
hospital 
64 76.63 18 60.74 0.93 (0.55-1.58) 237 71.87 69 77.63 0.87 (0.66-1.15) 
Others 22 42.81 6 89.89 1.86 (0.70-4.95) 65 35.00 10 26.77 0.86 (0.37-2.00) 
Hospital ownership  
Public 92 76.12 47 58.21 
0.86 (0.58-1.27) 





115 67.61 100 99.76 
1.05 (0.79-1.40) 
380 67.61 240 68.10 1.06 (0.88-1.27) 
Other  18 44.07 4 75.39 1.59 (0.47-5.33) 18 44.07 8 75.39 0.68 (0.23-2.03) 
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Geographic location  
Taipei  53 64.06 26 59.31 0.88 (0.53-1.45) 164 48.06 89 58.39 0.93 (0.89-1.24) 
Northern 21 47.63 14 80.45 1.12 (0.43-2.91) 87 51.45 39 42.69 0.63 (0.38-1.07) 
Central 46 70.86 47 92.83 1.07 (0.69-1.66) 87 43.15 146 87.07 1.17 (0.85-1.61) 
Southern 50 98.09 22 69.12 0.73 (0.40-1.33) 199 94.06 80 76.25 
0.75 (0.56-
0.99)* 
Kao-Ping 49 72.62 32 108.58 1.64 (0.95-2.80) 201 57.94 72 82.60 1.06 (0.78-1.43) 
Eastern 6 27.76 10 76.23 1.38 (0.36-5.38) 50 59.06 18 46.91 0.99 (0.49-2.02) 
Physician characteristics 
Age, year           
< 35 35 80.27 29 11.543 1.08 (0.62-1.89) 111 52.60 61 73.76 1.32 (0.91-1.92) 
35-64 189 66.79 122 76.34 0.97 (0.76-1.24) 672 59.73 382 69.54 0.91 (0.79-1.05) 
>=65 1 19.13 0 0.00 -- 5 26.53 1 10.07 -- 
Gender            
Female  7 43.82 8 52.46 0.71 (0.19-2.60) 23 31.34 18 39.35 0.61 (0.22-1.69) 
Male  216 68.52 143 83.61 1.00 (0.80-1.26) 762 59.51 426 71.45 0.95 (0.83-1.08) 
Specialty           
Chest 
Medicine 
64 66.33 98 86.95 0.85 (0.61-1.19) 200 51.81 280 66.31 0.96 (0.79-1.18) 
Infectious 
Disease 
4 59.29 13 109.39 0.46 (0.12-1.80) 31 77.39 26 87.19 1.36 (0.64-2.89) 
Family 
Medicine 
6 31.93 1 150.74 -- 33 45.53 4 89.66 1.54 (0.41-5.70) 
Tuberculosi
s Specialist 
84 83.67 16 54.23 0.76 (0.43-1.35) 278 69.93 60 73.96 0.76 (0.57-1.02) 
General 
Medicine  
38 61.48 20 80.76 1.15 (0.65-2.04) 151 61.44 62 76.14 1.08 (0.78-1.51) 
  Other 29 60.95 3 44.37 1.04 (0.28-3.80) 95 44.57 12 52.52 0.85 (0.44-1.64) 
Rate, per 1000 person-years 
† Cox proportional hazards regression  
†Mode adjusted for patient characteristics , physician and practice characteristics, P4P participation and Charlson 
comorbidity index score (CCI) 




Using Kaplan-Meier for analyzing survival probability between TB patients with 
and without P4P by mood, we found that among both mood disorder and non-disorder 
TB patients, P4P program had no impact on survival (non-mood disorder log rank test p= 
0.11 (p＞0.05); mood disorder log rank test p= 0.22 (p＞0.05) ) (Fig. 4.2). From the 
results of Table 4.8, we stratified factors of mortality by patient, hospital, and physician 
characteristics. This also showed that P4P had no significant impact on mortality among 





Figure 4.3  Survival probability between TB patients with and without P4P in Kaplan-Meier 




5. CHAPTER FIVE: DISCUSSION AND IMPLICATIONS  
5.1 Summary of findings 
In summary, our epidemiological study provides an exploration of the prevalence of 
mood disorder among TB patients and the relationship between risk of mood disorder and 
TB treatment outcome. We estimated the prevalence of mood disorder among TB 
patients to be 12.6% in Taiwan, which was higher than the prevalence in the general 
population. Anxiety was the leading mood disorder (83.4%). Elderly, females, high-
income patients, disabled patients, and patients with a high CCI score had a significantly 
higher chance of having a mood disorder. Patients with a mood disorder were less likely 
to participate in the P4P program and had a higher default rate than patients without a 
mood disorder. Risk factors for patients’ default are having a mood disorder and being 
female. Regional level hospitals and family medicine specialties had the highest default 
rate. Patients with a mood disorder, elderly patients, males, lower-income patients, 
patients with a disability, and patients with a high CCI had significantly higher risk of 
increasing mortality. P4P on TB program can decrease the default rate had no significant 
influence on all-cause mortality. 
5.2 Discussion: 
5.2.1 Study aim 1: 
Research question 1: What is the prevalence of mood disorder among TB patients in 
Taiwan?  
Hypothesis 1: The prevalence of mood disorder is higher in TB patients than in the 
general population in Taiwan. 
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Discussion: The lifetime prevalence of mood disorder in patients with chronic disease is 
from 8.9% to 12.9% (Bernstein, 2004; Cassem, 1990). Previous studies found that the 
prevalence of mood disorder in patients with TB ranges from 11.3-80.2% (A. Sweetland, 
Oquendo, Wickramaratne, Weissman, & Wainberg, 2014). The estimated prevalence of 
mood disorder ranged from 13.3%-52.2% in Peru (Vega, et al., 2004), 22%-72% in 
Pakistan (Aamir & Aisha, 2010; Mohammed O Husain, 2008), 7%-10% in India 
(Rajeswari, 2005), 19%-25.6% in Turkey, and 21.1%-56.1% in China (Pan, et al., 2006). 
The wide range in these studies is attributed to the different scales used and the fact that 
most of the studies had a small sample size.  
In our study, psychiatric diagnosis, in particular, is made by qualified psychiatrists 
after professional clinical interviews. This is more reliable, considering the differential 
mood conditions of patients. Additionally, our datasets from the NHIRD had a large 
sample size and could be generalized. From our results, the prevalence of mood disorder 
in the general population in Taiwan was 12.6%, which is close to that in the UK and the 
United States. Since tuberculosis is a disease that impacts both the individual and society, 
patients’ first react to the diagnosis with tension/anxiety (30%), loss of 
interest/depression (26%), denial (6%) and suicidal thoughts (9%) (Rajeswari, 2005; 
Shen et al., 2014; U Eram, 2006). Our study estimated that 26.8% of TB patients in 
Taiwan have a mood disorder, which was two times higher than the prevalence of mood 
disorder in the general population. It was not surprising that anxiety (83.4%) was the 
most common mood disorder. These emotional problems may be explained by feelings of 
stigma, discrimination, and social isolation associated with TB. Therefore, individuals 
diagnosed with TB are more likely to be psychological distressed than the general 
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population. Our results indicate high mood disorder morbidity in TB patients, as 
consistent with other studies.  
Research question 2: Among TB patients, what patient characteristics are associated 
with the presence of mood disorder in Taiwan?  
Hypothesis 2 : Patient’s age, gender, socio-economic status, location of residence, 
disease severity, and other co-morbidities are associated with the presence of mood 
disorder among TB patients. 
Discussion: A previous study examined the association between burnout, depression, 
anxiety, and inflammation as risk factors for cardiovascular disease (Chung et al., 2014). 
Researchers used C-reactive protein as a specific protein biomarkers for measuring 
inflammation. They discovered that there was an association between burnout and 
inflammation in women but not in men. Depression, not burnout or anxiety, produced 
similar elevated levels of inflammation in men (Suarez, 2004; Toker, Shirom, Shapira, 
Berliner, & Melamed, 2005). When women are diagnosed with TB, they may experience 
loss of intimacy with their husbands, damage relations with children and relatives, and be 
avoided by neighbors or colleagues. People who perceived stigma may have a low self-
image and be socially isolated, which may predispose them to common mental disorders 
(Deribew et al., 2010). Thus, these physical and psycho-social risk factors make women 
more prone to mood disorders than men.  
Implication: It is important for primary care physicians treating patients with TB to be 
mindful of the clinical manifestations of mood conditions. Early appropriate psychiatric 
referral might identify patients with mood disorders. This may provide appropriate 




5.2.2.Study aim 2: 
Research question 3: Do TB patients with mood disorder have the same rate of 
treatment default rate as TB patients without mood disorder in Taiwan? 
Hypothesis 3: TB patients with mood disorder have a higher default rate than TB 
patients without mood disorder in Taiwan. 
Discussion: 
Under the national guidelines for TB diagnosis and treatment by the Taiwan CDC 
(TCDC, 2015), first line medications include rifampin, isoniazid, pyrazinamide and 
ethambutol. The suggested treatment duration is six months in general, and nine to twelve 
months for retreatment or complex patients. It is not easy for patients to adherence to this 
long term treatment-taking behavior. It had been reported that up to half of all of patients 
with TB do not complete treatment (Cuneo & Snider, 1989; Menzies, Rocher, & 
Vissandjee, 1993). Unfortunately, after tuberculosis onset, emotional disturbance will 
also appear because of psychological issues such as stigma, isolation, sense of little social 
support, helplessness, and other psychological reactions to the disclosure of the diagnosis 
as well as medication side effects, all of which adversely affect the treatment adherence. 
Based on our study results, patients with mood disorder were less likely to participate in 
the P4P program and had higher default rates than patients without mood disorder. Our 
study found that mood condition may play as a barrier to treatment adherence. This is 
consistent with previous research which suggests that mood disorder may contribute to 
TB prolonged infection, drug resistance, relapse, and death (Canaza et al., 2013; Volmink 
& Garner, 2007). In addition, our results show that no comorbidity patients were more 
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likely to participate in the P4P program, but the more comorbidities they have the less 
likely to default to TB treatment. This is possibly due to a fear of becoming more ill and 
having to strictly follow the physician’s advice. In order to increase the positive treatment 
outcomes of tuberculosis patients, comorbidities must be firstly identified and treated.  
 Gender was an interesting factor in our study finding. Females were more likely 
to develop mood disorders, but less likely to participate in the P4P program, and had 
more interrupted treatment than male. Gender differences in treatment adherence is still 
divergent in many studies (Alobu, Oshi, Ukwaja, & Oshi, 2015; Johansson, Long, Diwan, 
& Winkvist, 1999; Y. H. Li, et al., 2010). Some studies debated that a female patient’s 
role and responsibilities in the family could motivate them to adhere to treatment in order 
to recover and resume those duties (Khan, Walley, Witter, Shah, & Javeed, 2005; 
Krishnan et al., 2014; Y. H. Li, et al., 2010; SS Sarpal, NK Goel, D Kumar, & Janmeja, 
2015; Wares, Singh, Acharya, & Dangi, 2003). Other studies found that responsibilities 
in the home, such as providing income and caring for children, also reduced the 
likelihood of treatment adherence for women (Greene, 2004). We believed that “gender” 
refers not only to the physiological differences between sexes but also to the variety of 
health seeking behaviors, expectations, and roles that exist within a social, economic, and 
cultural context (Y. Li et al., 2013). Logically both males and females are infected, 
progress to disease, and die due to tuberculosis. Also, males and females share many 
similar beliefs and attitudes about tuberculosis. However, there are considerable 
differences with regard to stigma and its social consequences. Not just the individuals but 
the whole family may also suffer from social stigma and its negative consequences, 
which make the female family members feel suffering. Previous research mentioned a 
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relationship between pregnancy and non-adherence to TB treatment (Fong, 2004). 
Female patients who were, or wanted to be, pregnant were less likely to adhere to 
treatment as they perceived the medication to be harmful. Two more studies also found 
that women diagnosed with TB during pregnancy are at increased risk for having low 
birth weight and small for gestational age infants (Jana, Barik, & Arora, 2010; Lin & 
Chen, 2010). Females feel guilt over the TB medication impact on their baby, which may 
cause them to be hesitant about continuing treatment. Moreover, Genital TB has shown to 
be cause of infertility (Hardy & Anderson, 2015). Physicians should be aware of the 
potential maternal and fetal adverse outcomes for women diagnosed with TB and practice 
more intensive monitoring during pregnancy. 
 Stigma may lead to delays for both sexes in seeking care, but more so for females 
if there are physical, geographical, and economic barriers to health care (Alobu, et al., 
2015; Anderson de Cuevas et al., 2014; Balasubramanian et al., 2004; Chen et al., 2014; 
Ting et al., 2014). Although there has been increased advancements in gender equality, 
the social expectation of a female role is not only as a caregiver to the family and home, 
but also comes with the need to be working and sharing responsibilities of raising 
families.  
Stigma may also make patients afraid to ask for support from their employer. 
Studies suggested that patients hide their disease for fear that employers may discover 
that they have TB, fear of obtaining sick leave for treatment and fear of losing work or 
dismissal (Greene, 2004; Johansson, Diwan, Huong, & Ahlberg, 1996; Johansson, et al., 
1999). Several studies noted that, in some cultures, a man is perceived as superior to a 
woman, and thus men's health is prioritized. Women are expected to care for husbands 
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with TB but men are not expected to care for wives with TB. (Balasubramanian, et al., 
2004; Chen, et al., 2014; Johansson, et al., 1996; Johansson, et al., 1999; Liam, Lim, 
Wong, & Tang, 1999; Sanou, Dembele, Theobald, & Macq, 2004; Ting, et al., 2014). 
This attitude is still prevalent in Taiwan, particularly in rural areas. Hence, empowering 
women and encouraging families to give them support is very important for women 
(WHO, 2015a). It may include emotional and financial support, and a temporary 
substitution for the female's caregiver role.  
 In Taiwan, the National Health Insurance (NHI) program was implemented in 
1995. As a result, utilization and accessibility of health care services have greatly 
improved. The NHI is a compulsory universal health program that offers complete 
freedom of choice of health care providers and allows TB patients to seek free medical 
aid from any health care institution or any primary practitioner. In our study, higher 
default rate in patients was observed more often among family medicine doctors than in 
chest medicine doctors. This is likely due to the physicians’ expertise with TB. Chest 
medicine doctors were more likely to recruit their patient to P4P on TB program. This is 
consistent with other research that shows that patients treated by pulmonologists 
appeared to have higher treatment success rate than those treated by non-pulmonologist 
physicians (Chung, et al., 2007). A pivotal factor may be the unfamiliarity of physicians 
with the treatment of TB. Patient with a more strict out-patient follow-up procedure and 
more scrupulous patient education programs will have better success in treatment. 
Training for care providers and the institution providing the care is an important factor 
that affects the quality of care.   
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For most patients, access to a health care facility depended on distance, available 
transportation, as well as their physical condition. Studies have noted that access to health 
care facilities was better in urban areas than rural areas (Johansson, et al., 1996; Liam, et 
al., 1999). In our study, district and regional level hospital had more P4P participation but 
regional hospitals had highest default. This may be explained by the fact that most of the 
lower level hospitals are located in rural areas. The referral system is insufficient, with 
relative lack of medical resources in rural areas, especially for patients with comorbidities.  
 
5.2.3 Study aim 3 
Research question 5: Does P4P with the TB program improve TB  treatment default 
rate among TB with mood disorder patients ? 
Hypothesis 5: TB patients with mood disorder enrolled in the P4P program have a higher 
default rate than those patients who are not enrolled in the P4P program in Taiwan.  
Discussion: 
The results of this study show that the P4P program has had a positive effect on 
outcome for TB patients. Patients in P4P on TB programs had significantly lower default 
in both with and without mood disorder TB patients. However, in Taiwan there are still a 
few hospitals that refused to participate this program. There are several reasons for this, 
and the incentives are different by stage of treatment. Hospitals must follow the P4P 
contract; whenever they enroll one hundred new TB cases, they must hire an extra case 
manager. This case manager coordinates with the patient, the hospital, the community, 
and the government’s CDC. Cooperation between professionals in multidisciplinary 
teams tends to vary widely across hospitals. This extra work is costly but is not rewarded. 
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Therefore some hospitals, especially those in which multidisciplinary teams, are not well 
coordinated. They are also concerned that the P4P program on TB could reduce total 
payment for an enrolled patient if the patient does not complete the full care package per 
the treatment plan and reduce the bonus based on patient's TB treatment outcome such as 
negative sputum finding and chest X-ray. The treatment procedure is divided into 4 
phases (each 3 months), and health care providers receive bonuses if they complete the 
uninterrupted case management procedure in each phase. Otherwise, the reimbursement 
switches to the standard non-bonus scheme afterward as a punishment. As compared to 
treat multiple drug resistant TB patients, this program pays a more generous bonus. Thus, 
hospitals are reluctant to take over the multiple drug resistant or complex cases to avoid 
increasing their cost. As a result, some hospitals prefer to retain the original payment 
scheme so as to reduce financial risk in the case of incomplete treatment or overuse of 
resources due to complications.  
Implications: Many studies suggested that better TB treatment adherence resulted in 
better outcomes, and reduced burden of cost and drug resistance. Mood disorder is 
associated with poor adherence to medication in the treatment of TB. Screening and 
follow-up for mood disorders are recommended for TB patients, which could reduce the 
TB burden by increasing treatment adherence. In addition to medical treatment, mental 
health support for TB patients may also lead to improved treatment outcomes. The 
findings could help inform the development of patient-centered interventions and 
interventions to address barriers to treatment adherence. In order to increase positive 
treatment outcomes for TB patients with mental health conditions, comorbidities must be 
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firstly identified and treated. Health workers also need to better understand the effects of 
gender, age and social aspects of tuberculosis control. 
 
Research question 4: Do TB patients with mood disorder have the same mortality as TB 
patients without mood disorder in Taiwan?  
Hypothesis 4: TB patients with mood disorder have a higher mortality rate than TB 
patients without mood disorder in Taiwan. 
Research question 6: Does P4P with TB programs improve the effectiveness of TB 
treatment among TB patients with mood disorders in terms of TB mortality. 
Hypothesis 6: TB patients with mood disorder enrolled in the P4P program will have a 
lower mortality rate than those patients who are not enrolled in the program in Taiwan. 
Discussion: 
Mortality studies have contributed considerably as indicators of health care quality for 
inpatient and outpatient services. Our study investigated all-cause mortality among TB 
patients with and without mood disorder from the year 2002 to 2010 ( a total of nine 
years of follow-up time). We found that TB patients with mood disorder had an 1.8-fold 
increased risk of all-cause mortality than patients without mood disorder. Mood disorder 
may contribute to negative TB outcomes in several ways. TB may increase risk of 
depression or worsen the depression symptoms due to increased symptom burden, 
increased in inflammatory factors, and decreased quality of life (Suarez, 2004; Toker, et 
al., 2005). Comorbid mood disorder has been found to impair the ability to perform self-
care activities, reduce total life expectancy significantly, and increase overall mortality by 
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almost two-fold (Cuijpers & Smit, 2002; Reynolds, Haley, & Kozlenko, 2008). Our 
results are consistent with previous studies.  
 In our study, the mortality rate of TB patients in Taiwan increased with age. TB 
prevention in the oldest age group (⩾65 years) is more difficult due to comorbidities and 
other factors. A recent study found that elderly patients with chronic kidney disease, 
stroke, or chronic liver disease as a comorbidity were more likely to die from TB-specific 
causes (Chu, Wu, Lo, Yang, & Chou, 2015). The increase in longevity of the general 
population of Taiwan has led to a larger pool of individuals with increased susceptibility 
to a flare-up of latent tuberculosis. It has been assumed that the high rate of tuberculosis 
in the elderly could also be due to the high rate of infection experienced in childhood or 
as young adults (Frost, 1995). After World War II, BCG vaccine was introduced to 
Taiwan in 1951. Fortunately, the youngest group (age <45) had received BCG vaccines 
in their childhood.  
 In previous research, aging has been revealed to be associated with progressive 
immune dysregulation. The most important finding is a progressive decrease in the CD8+ 
T-cells (Davies, 1999; Lesourd, 2004). This degeneration of the immune system makes 
the elderly more prone to infection or disease relapse. Cause of death in our study varied. 
Since most of the TB patients were of old age and many patients' had poor and 
complicated physical conditions, there was a combination of a lot of serious 
comorbidities. Patients in the end stage of cancer, or on the verge of dying or cachexia, 
have lower immune system function which may cause past TB to be reactive. Therefore it 
is difficult to distinguish whether the death was related to TB or other comorbidities. As 
most TB incidence among the elderly is due to reactivation of old TB, death certificates 
 
 96 
were incorrect in most of these cases, with old TB being listed as a contributing factor 
and not directly related to the cause of death. Sometimes people died for TB while having 
had other diseases, and the Death Registry may not code TB as the major cause of death. 
Therefore, the true number of TB deaths was possibly higher than we estimate. Thus, 
further research may consider using primary medical chart review to explore this issue.  
 In addition, socio-economically deprived people in Taiwan are a vulnerable group. 
Poor older patients are less well-off than younger patients Poverty and poor nutritional 
status, in addition to mood disorder, are risk factors for high rates of tuberculosis in the 
elderly. Old age is significantly associated with treatment failure and death.  
Implication: Reduction in mortality is possible through various interventions such as 
improved nutrition, urbanization, vaccination, medical treatment, and health education.  
 
5.3  Policy Implications  
This study explored the prevalence and the impact of mood disorder on TB patients, as 
well as how the P4P on TB program plays a role in the treatment of comorbid TB and 
mood disorder compared to only TB. From the results of this study, we provided 
policymakers with information on the impact of comorbid mood disorder and TB and the 
role of the incentive program. The government might decide whether or not to reinforce 
or improve the current TB control plan. Policies that may mitigate the influence of mood 
disorder on TB are suggested in the next section. 
5.3.1  Developing a mood screening tool for TB patients and constructing a 
mental status follow-up system in TB registry management files  
 
 97 
 Many mood screening tools have been used widely. They include: Hospital 
Anxiety and Depression scale (HADS), Beck Depression Inventory (BDI) and the Center 
for Epidemiological Studies Depression Scale (CES-D) for depression, Spielberger state-
trait anxiety scale and State-Trait Anxiety Inventory for anxiety. Some screening tools 
have too many questionnaires may make patients feel frustrated and tired of answering 
them. The mood disorder screening tool should be tailored and designed especially for 
TB patients. This screening tool may include: 
1).The Mood Disorder Questionnaires: questions about specific symptoms of mood 
disorder and anxiety, including how long the symptoms have been present. 
2). Ask whether they have caused problems in social relationships or work. 
3). Always ask about suicidal ideation.  
4). Add open-ended and non-leading general questions about the symptoms of emotional 
distress. Let patients be free to express themselves and their emotional condition. 
5). Interview patient's family or friends regarding emotional supports. 
6). Listen to the patient’s unprompted presenting complaints. 
 
5.3.2  Recruitment of psychological professionals to the TB care team and 
reinforce the referral system 
 After initial pharmacotherapy and related clinical management, care should 
ideally be provided with a healthcare team that includes at least one other psychological 
professional in addition to the physician. While primary care physicians are treating 
patients with TB they need be mindful of the clinical manifestations of mood condition. 
 
 98 
Early appropriate psychiatric referral might identify patients with mood disorder and 
provide appropriate psychosocial support and medical aids sooner. 
 In Taiwan, a TB case manager is usually a nurse who contacts people in the 
hospitals for TB-related matters. The BNHI requires hospitals reporting over one hundred 
TB cases a year to have TB case managers. Usually, they are senior nurses who receive 
additional training and education about TB control. They track patients’ revisits, educate 
patients on health matters, update patients’ information in the central database, and 
coordinate patient management with public health nurses and local health officials. 
Essentially, TB case managers are responsible for all TB related matters in the hospitals.  
Case managers must be well trained for caring for patient's psychological conditions. 
Case managers may provide detailed psychological education, additional monitoring, and 
support. Monitoring involves active outreach and follow up of patients known to be 
severely ill, to ensure patients attend appointments and follow recommendations. Case 
managers involve the provision of robust psycho education, whose elements would 
include preparing the patient to become actively involved in self-management, 
identifying ways to collaborate most effectively with health providers, teaching key facts 
about bipolar disorder, teaching recognition of early signs of relapse, identifying a relapse 
drill, and learning a variety of key stress management techniques, including careful 
attention to sleep regulation and avoidance of medication misuse. The workload for case 
managers is very heavy. We recommend NHI Bureau provide more funds to recruit 
psychological professionals in care team.  
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5.3.3  Improvement of the mental care abilities and sensitivity to mood 
disorder among TB patients in all hospitals, particularly regional hospitals 
 The TB care providers need to have the capability to provide TB patients with 
more comprehensive care. Health departments should periodically hold TB education and 
training for healthcare providers.  
 In teaching health workers about TB control, we tend to concentrate on technical 
aspects, while there is a great need for better understanding of behavioral factors and for 
developing strategies, that take these into account. When we improve the care capabilities 
of hospitals, the whole setting such as work environment, equipment and facilities, 
communication, management and leadership must be taken into account simultaneously. 
This may include minimizing costs and unpleasantness related to clinic visits and 
increasing flexibility and patient autonomy. 
 
5.3.4  Patient-centered approach 
The "disease-oriented" care model in the past may not enough to satisfy patients' need. A 
patient-centered" approach is a better way to provide care for this unique group. For 
example, gender sensitive strategies need to be developed in order to solve problems and 
fit the patients’ cultural background and special needs. Comprehensive services are of 
importance at all levels of the health system, in order to make them more accessible and 
affordable, for both men and women. 
 The strategies may involve elements of a healthcare system for effective care of 
TB with mood disorders patients, such as:  
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Self-management support: to empower vulnerable groups such as elderly, female, low 
socio-economic and disability groups, and prepare patients to manage their health and 
health care.  
TB education in communities: to provide TB education and increase the visibility of TB 
programs in the community, which may increase knowledge and improve attitudes 
towards TB. This program may provide more information about the disease and treatment 
to patients and communities. We need to encourage communities to increase TB patients 
support from family, peers, and social networks. 
Health system: to reconsider the delivery system design for TB patients, to reduce their 
waiting time, keep their privacy, and reduce their barriers of transportation to visit 
hospitals.  
 
5.3.5  Empowering women for break barrier  
In 2013, WHO reported an estimated 3.3 million women falling ill with TB. The vast 
majority of TB deaths are in the developing world where gender inequities are very 
common. TB among mothers is associated with a six-fold increase in prenatal deaths and 
a two-fold risk of premature birth and low birth-weight. We need to mobilize at global 
and national levels to assure gender-equitable access, including women friendly services 
to TB prevention, diagnosis, treatment care and support. TB, HIV, maternal, neonatal and 
child health programs, and primary care services should collaborate to maximize the 
entry points to TB care for women at all levels. We should integrate TB screening and 
investigation into reproductive health services, including family planning, antenatal and 




5.3.6  TB Patient club and internet  
Compared to patient clubs for other disease, it is rare to see TB patient clubs in our 
society. This is probably because of stigma and fear of discrimination or society’s fixed 
impression of contagious disease. In this internet generation, we may use internet sites 
such as Face book or Line to form support groups. The internet has the advantages of 
keeping patient's privacy, breaking isolation and breaking the time, spatial and distance 
limitation. Patients could support each other in adhering to treatment, and to share 
information about the course of the disease and possible drug side effects through their 
treatment course. They also can clarify some misconceptions about the effects of 
medication to reduce the risk of patients becoming non-adherent when experiencing 
treatment side effects. 
 
5.3.7  Law and legislation: anti-discrimination  
TB patients' discrimination and exclusion are a long-standing social phenomenon. This 
social phenomenon is not reduced by social progress and civilization. In recent years, TB 
discrimination events are still been reported frequently. In 2007, a graduate student was 
denied admission by Guangzhou Institute of Geochemistry, because of his TB suspected 
laboratory results. Even by physician's guarantee that his condition was not contagious, 
the school still insisted on its decision. This was the first lawsuit against discrimination to 
protect TB patients’ right to education in China (zjh, 2011). Taiwan also had the same 
issues. A college student was prohibited from presenting in her class because she was 
diagnosed TB.   
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 Although TB can be spread to others, it is not as contagious as many airborne 
viral infections, such as measles and chicken pox. A single or a casual contact with an 
infectious person in a public place (such as subways, airplanes, movie theaters or on 
campus) usually does not cause the transmission of TB. The infectiousness of patients 
diminishes rapidly once effective treatment is initiated, as long as the patient adheres to 
the treatment regimen. Within two weeks of starting medication, the patients may become 
noninfectious. According our communicable Disease Prevention Law Article 16, any unit 
or individual shall not discriminate against patients with infectious diseases, pathogen 
carriers or suspected patients with infectious diseases. For patients with early stage or 
non-infectious tuberculosis, they still shall be entitled by the Constitution of basic human 
rights. TB patients should have the right to life, the right to learn, the right to work, the 
right of privacy, drug management rights, personal liberty, and the right to freedom of 
residence.  
 The government should reconsider whether the law has enough protection 
capabilities. Continuing examination of the legal basis and investigation of the actual 
practice are needed. It is necessary to educate people (including schools, communities, 
government agencies, and organizations), in order to change the public's negative stigma 
of TB, and to protect the basic human rights of patients. 
 
5.4  Strengths and Limitations 
This study may be subject to several limitations and threats. First, only TB patients in 
Taiwan are included in the study. The unique culture and healthcare system in Taiwan 
may limit the study results to be inapplicable to other geographical areas or other nations. 
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Second, the analysis was from claimed data that was definitely influenced by medical 
resource utilization behavior. For example, untreated patients were not included. Third, 
the outcome measures used in the study may be limited, encompassing only patient 
outcomes, and not representing all dimensions of the quality of care that TB patients 
receive. For example, the quality of diagnosis, additional support, and monitoring of TB 
patients by the participating hospitals in the P4P program are not evaluated and compared. 
In addition, rewards might largely depend on patient adherence to treatment plans as well 
as patient lifestyle. As patient lifestyle cannot be identified through claims data, it was 
not controlled for in this study. Moreover, the study may be subject to a bias that TB 
patients treated by the participating hospitals and non-participating hospitals may be 
different (for example, in terms of their disease severity and socio-economic status). 
Although I adjusted for many patient and hospital characteristics to control for these 
differences, there may be some unobservable confounders. For example, patients who are 
better in self-disease management may be more likely to look for better care and will be 
treated in the program-participating hospitals. However, I do not expect that this patient 
self-selection will be a serious threat to this study because the BHNI and participating 
hospitals did not promote this program in the general patient population. Most of the 
patients were therefore unaware of this P4P program. TB patients had no information to 
look for to be treated by these participating hospitals. Moreover, all TB treatment 
expenses were covered by the national health insurance with limited copayments, which 
might also reduce the possibility that patients with better socio-economic status were 
treated by participating and better equipped hospitals. 
 In spite of the limitations mentioned, there are strengths and new contributions 
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gained from this study. First, this study observes all TB patients in Taiwan, which 
provides a large study population and makes it possible to describe the co-morbidity TB 
and mood disorder, as well as to evaluate the impact of mood disorder on the TB 
treatment. Moreover, this study provides more information on the P4P on TB program in 
Taiwan. Though the program has been evaluated by a few studies that have shown its 
positive effects on TB treatment completion, default rate, and mortality, this study 
provides more information about whether this program also benefits TB patients with 
mood disorder, a group of patients that is more challenging treat. The study’s results also 
shed light on the evaluation of a P4P program focused on a disease with a clear treatment 
course and outcome.  
 
5.5  Future Research 
Our results showed epidemiological information of the differences between men and 
women in prevalence of TB infections, prevalence of mood disorder among TB infection, 
rate of progression from infection to TB, and mortality. Yet, it is unclear why more males 
than females are diagnosed with tuberculosis. Research on gender and tuberculosis that 
combine biological and social factors within this field is insufficient. Sex-specific 
biological characteristics in tuberculosis patients have been a neglected area for research, 
and need to be acknowledged and explored in the future. Aging effects and psychosocial 
factors are complex. Whether and how these variables contain the causal relationship also 
need to be further examined. 
From our study findings, the regional hospitals and below regional level hospitals 
had higher P4P participation rates than medical centers, but also had poor treatment 
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outcome. Whether their capacity is too limited to handle the extra work required by the 
program or whether a more generous bonus could improve their performance requires 
further investigation.  
Furthermore, the NHI research dataset lacks patient's life style, weather, and 
environment factors. In recent years, air pollution has been noticed to negatively 
influence human's health, especially particulate matter having a diameter of less than 2.5 
μm (PM2.5). This impact had been reported in Wuhan, China and in North Carolina, 
USA. (Chart-Asa & Gibson, 2015; Jakubiak-Lasocka, Lasocki, Siekmeier, & Chlopek, 
2015; Liu, Skjetne, & Kobernus, 2013; X. Yang, Duan, Wang, Zhang, & Jiang, 2014). 
Taiwan is a small island but has high population density. The seasonal wind blows from 
the southwest of Taiwan during the summer monsoon and from the northeast in October 
to April. It brings numerous small particulate to Taiwan. Whether patient contact during 
the high peak of commuting times and overcrowding during festival and family 
gatherings will quicken spread TB and induce emotional stress, it is still unclear.  
Further research may focus on the association between pulmonary TB and outdoor air 
pollutants, seasonal variation, temperature, or long-term exposure to particulate matter 
(PM) 2.5 concentration.  
 
5.6  Conclusion 
Our findings indicated that mood disorder serves as a major barrier to treatment 
adherence. TB patients with mood disorder had significantly lower survival rates. P4P on 
TB program can decrease default but had no significant influence on all-cause mortality. 
Our results suggest that mental health evaluation and treatment should be regularly 
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incorporated in the management of TB patients. There is a need to provide adequate tools 
to the clinician to identify and manage these patients at this primary care level. Early 
appropriate psychiatric referral may identify patients with mood disorder. TB psychiatric 
co-morbidity must be first identified and treated. Managing coexisting psychiatric 
disorder can alter the course of TB. Providing family support is very important for 
women; this may include emotional and financial support, and a temporary substitute the 
female's caregiver role. Old age was significantly associated with treatment failure and 
death. Through various interventions such as improved nutrition, urbanization, 
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Appendix A : 
 The rewards of P4P on TB program by stage of the TB treatment (TCDC 2002): 
1) First stage (Identification of the disease and continuous medication for three months): 
The payments include medical care payment for the disease manager for the 1
st
 stage 
(1,500 points) and a physician payment for 500 points. The total payment for this stage is 
2,000 points. 
2) Second stage (Continuous medication from 4
th
 month to 6
th
 month): Payments include 
medical care payment for the disease manager for the 2nd stage (1,500 points). If the 
cases are cured within 6 months, the case physicians can receive 1,000 points for the 
medical case payment. 
3) Third stage (Continuous medication from 7th month to 9th month): The payments 
include the medical care payment for the disease manager for the 3rd stage (500 points). 
If the cases are cured within 9 months, the case physicians can get 1,000 points for the 
medical case payment. 
4) Fourth stage (Continuous medication from 10th month to 12th month): Medical care 
payment for the disease manager is paid monthly (500 points). The case physician can 
receive 1,000 points when the cases are cured. If the cases are of multidrug-resistant 
tuberculosis, the hospital can declare a special fee for the case manager for 2,000 points, 
and the special case physicians can receive 1,000 points for providing medical care. After 
13 months, the case manager will not get any more payments for medical care, except 









A. Definitions of Tuberculosis Cases 
Case of Tuberculosis: A case of TB which has been bacteriological confirmed, or 
has been diagnosed by a clinician. 
Definite Case: Patient with positive culture for the Mycobacterium tuberculosis 
complex. In countries where culture is not routinely available a patient with two 
sputum smears positive for acid-fast bacilli (AFB+) is also considered a definite 
case. 
Pulmonary Case: A case of TB disease involving the lung parenchyma. 
Smear-Positive Pulmonary Case: At least two initial sputum smear examinations 
(direct smear microscopy) AFB+; or one sputum examination AFB+ and 
radiographic abnormalities consistent with active pulmonary tuberculosis as 
determined by a clinician; or one sputum specimen AFB+ and culture positive for M. 
tuberculosis. 
Smear-negative Pulmonary Case: Pulmonary tuberculosis not meeting the above 
criteria for smear positive disease. Diagnostic criteria should include: at least three 
sputum smear examinations negative for AFB; and radiographic abnormalities 
consistent with active pulmonary TB; and no response to a course of broad-spectrum 
antibiotics; and decision by a clinician to treat with a full course of ant tuberculosis 
therapy; or positive culture but negative AFB sputum examinations. 
Extra-pulmonary Case : Patient with tuberculosis of organs other than the lungs 
e.g. pleura, lymph nodes, abdomen, genitourinary tract, skin, joints and bones, 
meninges. Diagnosis should be based on one culture-positive specimen, or 
histological or strong clinical evidence consistent with active extra pulmonary 
disease, followed by a decision by a clinician to treat with a full course of anti-
tuberculosis chemotherapy. Note: a patient diagnosed with both pulmonary and extra 
pulmonary tuberculosis should be classified as a case of pulmonary tuberculosis. 
New Case: Patient who has never had treatment for tuberculosis, or who has taken 
anti-tuberculosis drugs for less than one month. 
Relapse Case : Patient previously declared cured but with a new episode of 
bacteriologically positive (sputum smear or culture) tuberculosis. 
Re-treatment Case: Patient previously treated for tuberculosis, undergoing 





Definitions of treatment outcomes (World Health Organization, 2005) 
Cured: Initially smear-positive patient who was smear-negative in the last month of 
treatment, and on at least one previous occasion. 
Completed treatment: Patient who completed treatment but did not meet the 
criteria for cure or failure. 
Died: Patient who died for any reason during treatment. 
Failed: Smear-positive patient who remained smear-positive at five months or later 
during treatment. 
Defaulted: Patient whose treatment was interrupted for two consecutive months or 
more. 
Transferred out: Patient who transferred to another reporting unit and for whom the 
treatment outcome is not known. 
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